Surgical instruments and end effectors therefor

Information

  • Patent Grant
  • 9456864
  • Patent Number
    9,456,864
  • Date Filed
    Monday, February 3, 2014
    10 years ago
  • Date Issued
    Tuesday, October 4, 2016
    7 years ago
Abstract
An end effector for use with a surgical instrument is disclosed. The end effector comprises a first jaw, a second jaw, wherein the first jaw is movable relative to the second jaw to transition the end effector between an open configuration and an approximated configuration to clamp tissue between the first jaw and the second jaw, and a camming assembly. The camming assembly comprises a first camming member comprising a first distal camming portion, a first proximal camming portion, and a first flexible portion extending between the first distal camming portion and the first proximal camming portion. The camming assembly further comprises a second camming member and a connector at least partially disposed between the first camming member and the second camming member, wherein the camming assembly is movable relative to the end effector to transition the end effector to the approximated configuration.
Description
BACKGROUND

Various embodiments are directed to surgical instruments that may be used, for example, in open and minimally invasive surgical environments.


In various circumstances, a surgical instrument can be configured to apply energy to tissue in order to treat and/or destroy the tissue. In certain circumstances, a surgical instrument can comprise one or more electrodes which can be positioned against and/or positioned relative to the tissue such that electrical current can flow from one electrode, through the tissue, and to the other electrode. The surgical instrument can comprise an electrical input, a supply conductor electrically coupled with the electrodes, and/or a return conductor which can be configured to allow current to flow from the electrical input, through the supply conductor, through the electrodes and the tissue, and then through the return conductor to an electrical output, for example. Alternatively, the surgical instrument can comprise an electrical input, a supply conductor electrically coupled with the electrodes, and/or a return conductor which can be configured to allow current to flow from the electrical input, through the supply conductor, through the active electrode and the tissue, and to the return electrode through the return conductor to an electrical output. In various circumstances, heat can be generated by the current flowing through the tissue, wherein the heat can cause one or more hemostatic seals to form within the tissue and/or between tissues. Such embodiments may be particularly useful for sealing blood vessels, for example. The surgical instrument can also comprise a cutting member that can be moved relative to the tissue and the electrodes in order to transect the tissue.


By way of example, energy applied by a surgical instrument may be in the form of radio frequency (“RF”) energy. RF energy is a form of electrical energy that may be in the frequency range of 300 kilohertz (kHz) to 1 megahertz (MHz). In application, RF surgical instruments transmit low frequency radio waves through electrodes, which cause ionic agitation, or friction, in effect resistive heating, increasing the temperature of the tissue. Since a sharp boundary is created between the affected tissue and that surrounding it, surgeons can operate with a high level of precision and control, without much sacrifice to the adjacent normal tissue. The low operating temperatures of RF energy enables surgeons to remove, shrink or sculpt soft tissue while simultaneously sealing blood vessels. RF energy works particularly well on connective tissue, which is primarily comprised of collagen and shrinks when contacted by heat.


Further, in various open and laparoscopic surgeries, it is necessary to coagulate, seal or fuse tissues. One preferred means of tissue-sealing relies upon the application of electrical energy to captured tissue to cause thermal effects therein for sealing purposes. Various monopolar and bi-polar RF jaw structures have been developed for such purposes. In general, the delivery of RF energy to a captured tissue volume elevates the tissue temperature and thereby at least partially denatures proteins in the tissue. Such proteins, including collagen, are denatured into a pertinacious amalgam that intermixes and fuses together as the proteins denature or form new cross links. As the treated region heals over time, this biological “weld” is reabsorbed by the body's wound healing process.


In a typical arrangement of a bi-polar radiofrequency (RF) jaw, the face of each jaw comprises an electrode. RF current flows across the captured tissue between electrodes in opposing jaws. Most commercially available bi-polar jaws provide a low tissue strength weld immediately post-treatment.


During some procedures, it is often necessary to access target tissue that requires severe manipulation of the end effector. In such applications, it would be desirable to have a curved and/or articulatable end effector arrangement to improve access and visualization of the surgical area by the surgeon.


The foregoing discussion is intended only to illustrate various aspects of the related art in the field of the invention at the time, and should not be taken as a disavowal of claim scope.


SUMMARY

In various embodiments, a surgical instrument is provided. The surgical instrument comprises an elongate shaft and an end effector extending from the elongate shaft, the end effector comprising a first member and a second member, wherein the first member is movable relative to the second member to transition the end effector between an open configuration and an approximated configuration to clamp tissue between the first member and the second member. The surgical instrument further comprises a camming assembly movable along a curved path, the camming assembly comprising a first camming member, wherein the first camming member comprises a first distal camming portion, a first proximal camming portion, and a first flexible portion extending between the first distal camming portion and the first proximal camming portion. The camming assembly further comprises a second camming member, wherein the second camming member comprises a second distal camming portion, a second proximal camming portion, and a second flexible portion extending between the second distal camming portion and the second proximal camming portion. The camming assembly further comprises a connector at least partially disposed between the first camming member and the second camming member, wherein the connector comprises a cutting member at a distal portion thereof, and wherein the camming assembly is movable relative to the end effector to exert a camming force against the first member and the second member to transition the end effector to the approximated configuration.


In various embodiments, a surgical instrument is provided. The surgical instrument comprises an elongate shaft, an end effector extending from the elongate shaft, the end effector comprising a first jaw and a second jaw, wherein the first jaw is movable relative to the second jaw to transition the end effector between an open configuration and an approximated configuration to clamp tissue between the first jaw and the second jaw. The surgical instrument further comprises a bendable firing member movable along a non-linear path, the bendable firing member comprising a first bendable portion defining a first plane, the first bendable portion comprising a first camming surface at a distal portion thereof, a second bendable portion defining a second plane, the second bendable portion comprising a second camming surface at a distal portion thereof, and a connector defining a third plane intersecting the first plane and the second plane, wherein the connector comprises a cutting member at a distal portion thereof, and wherein the first camming surface and the second camming surface are configured to engage the first jaw and the second jaw respectively to transition the end effector to the approximated configuration.


In various embodiments, an end effector for use with a surgical instrument is provided. The end effector comprises a first jaw, a second jaw, wherein the first jaw is movable relative to the second jaw to transition the end effector between an open configuration and an approximated configuration to clamp tissue between the first jaw and the second jaw, and a camming assembly movable along a curved path. The camming assembly comprises a first camming member, wherein the first camming member comprises a first distal camming portion, a first proximal camming portion, and a first flexible portion extending between the first distal camming portion and the first proximal camming portion. The camming assembly further comprises, one, a second camming member and, two, a connector at least partially disposed between the first camming member and the second camming member, wherein the connector comprises a cutting member at a distal portion thereof, and wherein the camming assembly is movable relative to the end effector to exert a camming force against the first jaw and the second jaw to transition the end effector to the approximated configuration.





BRIEF DESCRIPTION OF THE DRAWINGS

Various features of the embodiments described herein are set forth with particularity in the appended claims. The various embodiments, however, both as to organization and methods of operation, together with advantages thereof, may be understood in accordance with the following description taken in conjunction with the accompanying drawings as follows.



FIG. 1 is a perspective view of an electrosurgical instrument according to one non-limiting embodiment of the present invention;



FIG. 2 is a side view of the handle depicted in FIG. 1 with a portion of the housing thereof omitted to illustrate various handle components;



FIG. 3 is a top view of an end effector according to one non-limiting embodiment of the present invention;



FIG. 4 is a partial perspective view of the end effector embodiment depicted in FIG. 3 in an open position;



FIG. 5 is a partial perspective view of a portion of a translatable member according to one non-limiting embodiment of the present invention with an alternative flexed position shown in phantom;



FIG. 6 is a perspective view of a portion of a translatable member according to another non-limiting embodiment of the present invention;



FIG. 7 is a partial cross-sectional perspective view of a translatable member according to another non-limiting embodiment of the present invention;



FIG. 8 is a perspective view of an electrosurgical instrument according to another non-limiting embodiment of the present invention;



FIG. 9 is a partial perspective view of an end effector of another non-limiting embodiment of the present invention in an open position;



FIG. 10 is another partial perspective view of the end effector of FIG. 9 in a closed position;



FIG. 11 is a cross-sectional view of the end effector of FIG. 10 taken along line 11-11 in FIG. 10;



FIG. 12 is a top diagrammatical view of the end effector of FIGS. 9 and 10 with alternative flexed positions being shown in phantom;



FIG. 13 is a perspective view of an electrosurgical instrument according to another non-limiting embodiment of the present invention;



FIG. 14 is a side view of the handle depicted in FIG. 13 with a portion of the housing thereof omitted to illustrate various handle components;



FIG. 15 is a side elevational view of an end effector according to another non-limiting embodiment of the present invention with the jaw members thereof in a closed position;



FIG. 16 is a partial perspective view of the end effector of FIG. 15 in an open position;



FIG. 17 is a top diagrammatical view of the end effector of FIGS. 15 and 16 with alternative flexed positions being shown in phantom;



FIG. 18 is a perspective view of a portion of another end effector according to another non-limiting embodiment of the present invention;



FIG. 19 is a perspective view of a portion of another end effector according to another non-limiting embodiment of the present invention;



FIG. 20 is a perspective view of a portion of another end effector according to another non-limiting embodiment of the present invention;



FIG. 21 is a side view of the end effector embodiment of FIG. 20 being used to dissect tissue;



FIG. 22 is a perspective view of an electrosurgical instrument according to another non-limiting embodiment of the present invention;



FIG. 23 is a cross-sectional view of the end effector depicted in FIG. 22 in a closed position;



FIG. 24 is a top cross-sectional view of the lower jaw of the end effector of FIG. 23 in a partially articulated position;



FIG. 25 is another top cross-sectional view of the lower jaw of FIG. 24 in a straight position;



FIG. 26 is a partial perspective view of an end effector according to another non-limiting embodiment of the present invention with a portion of a translatable member thereof shown in phantom;



FIG. 27 is a side elevational view of a portion of the translatable member depicted in FIG. 26 with the end effector jaw portions shown in phantom;



FIG. 28 is a perspective view of an electrosurgical instrument according to another non-limiting embodiment of the present invention;



FIG. 29 is a partial perspective view of a portion of an articulatable elongate shaft according to a non-limiting embodiment of the present invention;



FIG. 30 is a perspective view of a spine segment according to an embodiment of the present invention;



FIG. 31 is a cross-sectional view of the spine segment of FIG. 30;



FIG. 32 is a partial side elevational view of the articulatable elongate shaft depicted in FIGS. 29-31 attached to an end effector;



FIG. 33 is a side elevational view of an electrosurgical instrument according to another non-limiting embodiment of the present invention;



FIG. 34 is a side elevational view of the end effector depicted in FIG. 33, with alternative positions illustrated in phantom;



FIG. 35 is another side elevational view of the end effector of FIG. 34 engaging tissue;



FIG. 36 is a perspective view of an end effector according to another embodiment of the present invention; and



FIG. 37 is a cross-sectional view of a portion of the end effector of FIG. 36 taken along line 37-37 in FIG. 36.





Corresponding reference characters indicate corresponding parts throughout the several views. The exemplifications set out herein illustrate various embodiments of the invention, in one form, and such exemplifications are not to be construed as limiting the scope of the invention in any manner.


DETAILED DESCRIPTION

Various embodiments are directed to apparatuses, systems, and methods for the treatment of tissue. Numerous specific details are set forth to provide a thorough understanding of the overall structure, function, manufacture, and use of the embodiments as described in the specification and illustrated in the accompanying drawings. It will be understood by those skilled in the art, however, that the embodiments may be practiced without such specific details. In other instances, well-known operations, components, and elements have not been described in detail so as not to obscure the embodiments described in the specification. Those of ordinary skill in the art will understand that the embodiments described and illustrated herein are non-limiting examples, and thus it can be appreciated that the specific structural and functional details disclosed herein may be representative and illustrative. Variations and changes thereto may be made without departing from the scope of the claims.


Reference throughout the specification to “various embodiments,” “some embodiments,” “one embodiment,” or “an embodiment”, or the like, means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, appearances of the phrases “in various embodiments,” “in some embodiments,” “in one embodiment,” or “in an embodiment”, or the like, in places throughout the specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments. Thus, the particular features, structures, or characteristics illustrated or described in connection with one embodiment may be combined, in whole or in part, with the features structures, or characteristics of one or more other embodiments without limitation.


It will be appreciated that the terms “proximal” and “distal” may be used throughout the specification with reference to a clinician manipulating one end of an instrument used to treat a patient. The term “proximal” refers to the portion of the instrument closest to the clinician and the term “distal” refers to the portion located furthest from the clinician. It will be further appreciated that for conciseness and clarity, spatial terms such as “vertical,” “horizontal,” “up,” and “down” may be used herein with respect to the illustrated embodiments. However, surgical instruments may be used in many orientations and positions, and these terms are not intended to be limiting and absolute.


Various embodiments of systems and methods of the invention relate to creating thermal “welds” or “fusion” within native tissue volumes. The alternative terms of tissue “welding” and tissue “fusion” may be used interchangeably herein to describe thermal treatments of a targeted tissue volume that result in a substantially uniform fused-together tissue mass, for example, in welding blood vessels that exhibit substantial burst strength immediately post-treatment. The strength of such welds is particularly useful for (I) permanently sealing blood vessels in vessel transaction procedures; (ii) welding organ margins in resection procedures; (iii) welding other anatomic ducts wherein permanent closure is required; and also (iv) for performing vessel anastomosis, vessel closure or other procedures that join together anatomic structures or portions thereof. The welding or fusion of tissue as disclosed herein is to be distinguished from “coagulation”, “hemostasis” and other similar descriptive terms that generally relate to the occlusion of blood flow within small blood vessels or vascular zed tissue. For example, any surface application of thermal energy can cause coagulation or hemostasis—but does not fall into the category of “welding” as the term is used herein. Such surface coagulation does not create a weld that provides any substantial strength in the treated tissue.


At the molecular level, the phenomena of truly “welding” tissue as disclosed herein may result from the thermally-induced penetration of collagen and other protein molecules in a targeted tissue volume to create a transient liquid or gel-like pertinacious amalgam. A selected energy density is provided in the targeted tissue to cause hydrothermal breakdown of intra- and intermolecular hydrogen crosslink's in collagen and other proteins. The denatured amalgam is maintained at a selected level of hydration—without desiccation—for a selected time interval which can be very brief. The targeted tissue volume is maintained under a selected very high level of mechanical compression to ensure that the unwound strands of the denatured proteins are in close proximity to allow their intertwining and entanglement. Upon thermal relaxation, the intermixed amalgam results in protein entanglement as re-cross linking or repatriation occurs to thereby cause a uniform fused-together mass.


Various embodiments disclosed herein provide electrosurgical jaw structures adapted for transecting captured tissue between the jaws and for contemporaneously welding the captured tissue margins with controlled application of RF energy. The jaw structures of certain embodiments can comprise first and second opposing jaws that carry positive temperature coefficient (PTC) or resistance bodies for modulating RF energy delivery to the engaged tissue.



FIG. 1 shows an electrosurgical instrument 100 according to a non-limiting embodiment of the invention. Electrosurgical instrument 100 comprises a proximal handle 105, a distal end effector 200, and an introducer or elongate shaft member 106 disposed in-between. In various embodiments, end effector 200 comprises a set of operable-closeable jaws 220A and 220B. The end effector 200 may be adapted for capturing, welding, and transecting tissue, for example. First jaw 220A and second jaw 220B may close to thereby capture or engage tissue therebetween. First jaw 220A and second jaw 220B may also apply compression to the tissue. In alternative embodiments, the end effector may be comprised of one or two movable jaws.


Moving now to FIG. 2, a side view of the handle 105 is shown with half of a first handle body 106A (see FIG. 1) being removed to illustrate some of the components within second handle body 106B. Handle 105 may comprise a lever arm 128 which may be pulled along a path 129. Lever arm 128 may be coupled to a translatable member 140 that is disposed within the elongate shaft 106 by a shuttle 146 that is operably engaged to an extension 127 of lever arm 128. The shuttle 146 may further be connected to a biasing device, such as spring 141. The spring 141 may also be connected to the second handle body 106B, to bias the shuttle 146 and thus the translatable member 140 in a proximal direction, thereby urging the jaws 220A and 220B to an open position as seen in FIG. 1. Also, referring to FIGS. 1 and 2, a locking member 131 (see FIG. 2) may be moved by a locking switch 130 (see FIG. 1) between a locked position, where the shuttle 146 is substantially prevented from moving distally as illustrated, and an unlocked position, where the shuttle 146 may be allowed to freely move in the distal direction, toward the elongate shaft 106. The handle 105 can be any type of pistol-grip or other type of handle known in the art that is configured to carry actuator levers, triggers or sliders for actuating the first jaw 220A and second jaw 220B. Elongate shaft 106 may have a cylindrical or rectangular cross-section and can comprise a thin-wall tubular sleeve that extends from handle 105. Elongate shaft 106 may have a bore extending therethrough for carrying actuator mechanisms such as, for example, translatable member 140, for actuating the jaws 220A, 220B and for carrying electrical leads for delivery of electrical energy to electrosurgical components of end effector 200.


The elongate shaft member 106 along with first jaw 220A and second jaw 220B may, in some embodiments, be continuously rotatable in either a clockwise or counterclockwise direction, as shown by arrow 117 (FIG. 1), relative to handle 105 through, for example, a rotary triple contact. First jaw 220A and second jaw 220B can remain operable-closeable and openable while being rotated. First jaw 220A and second jaw 220B may be coupled to the electrical source 145 and controller 150 through electrical leads in cable 152 to function as paired bi-polar electrodes with a positive polarity (+) and a negative polarity (−) or alternatively monopolar electrodes with positive (+) polarity and a remote grounding pad with a negative (−) polarity.


The first jaw 220A may have a first elongate portion 221A that is pivotally coupled to a second elongate portion 221B of the second jaw 220B by, for example, pins, grunions, or other known attachment arrangement such that the first jaw 220A may be pivoted toward and away from the second jaw 220B as represented by arrow 251 in FIG. 4. Further, the first jaw 220A and second jaw 220B may each have tissue-gripping elements, such as teeth 243, disposed on the inner portions of first jaw 220A and second jaw 220B. First jaw 220A may comprise a first jaw body 231A with a first outward-facing surface 232A and a first energy delivery surface 235A. Second jaw 220B may comprise a second jaw body 231B with a second outward-facing surface 232B and a second energy delivery surface 235B. First energy delivery surface 235A and second energy delivery surface 235B may, for example, both extend in a “U” shape about the distal end of working end 200.


As can be seen in FIGS. 1 and 3, the elongate shaft 106 defines a first longitudinal axis A-A. In various non-limiting embodiments, the first and second elongate portions 221A, 221B of the first and second jaws 220A, 220B, respectively are aligned along a second axis B-B that is offset from the first axis A-A. As can be further seen in FIG. 4, the first jaw body 231A may have a curved distal portion 222A and the second jaw body 231B may have a curved distal portion 222B. FIG. 3 is a top view of the end effector 200 and illustrates an embodiment wherein the first jaw 220A and the second jaw 220B have substantially matching shapes. As used herein, the terms “substantially” and “substantially the same” refer to characteristics or components that are otherwise identical, but for the normal manufacturing tolerances commonly experienced when manufacturing such components. As can be further seen in FIG. 3, the distal tip portion 224A of the jaw body 231A as well as the distal tip portion 224B of the second jaw body 231B are preferably located within the diameter “D” or “footprint FP” (for elongate shafts 106 that do not have a circular cross-sectional shape) of the elongate shaft 106 such that the end effector 200 may be inserted through an opening that can accommodate the elongate shaft 106. The offset nature of the end effector 200 enables the jaws 220A, 220B to be provided with a curved or irregular portion that is curved relatively sharper than other jaw embodiments wherein the jaws are axially aligned with the elongate shaft 106. It will be understood that the jaws 220A, 220B may have various curved portions, provided that no portion of the jaws 220A, 220B protrude laterally outward beyond the diameter “D” or footprint FP of the elongate shaft 106 for a distance that might otherwise prevent the insertion through a lumen such as, for example, a trocar or the like unless it is deflectable thereby allowing insertion through such a lumen.



FIGS. 3-5 show a portion of translatable, reciprocating member or reciprocating “I-beam” member 240. The lever arm 128 of handle 105 may be adapted to actuate translatable member 240 which also functions as a jaw-closing mechanism. For example, translatable member 240 may be urged distally as lever arm 128 is pulled proximally along path 129. The distal end of translatable member 240 comprises a flanged “I”-beam that is configured to slide within slots 242 in jaws 220A and 220B. See FIG. 4. Translatable member 240 slides within slots 242 to open and close first jaw 220A and second jaw 220B. As can be most particularly seen in FIG. 5, the distal end of translatable member 240 comprises an upper flange 244 and a lower flange 246 that are separated by a web portion 248 that has a sharpened distal end 250 for cutting tissue. In various embodiments, the translatable member 240 may be fabricated from, for example, stainless steel or similar elastic materials or alternatively from the class of superelastic materials such as Nitinol or the like. In various embodiments, the upper flange 244 and the lower flange 246 of translatable member 240 may each be optionally provided with cutout portions 252. The cutouts 252 may be substantially V-shaped with their narrowest portion adjacent the web 248 and their widest portion opening at the lateral edge of the flange as shown in FIG. 5. The cutouts 252 in the upper flange 244 may be substantially aligned with like cutouts 252 in the lower flange 246. To facilitate relatively tight bending of the translatable member 240 (as illustrated in phantom lines in FIG. 5), the cutouts 252 may be oriented relatively close together. Such translatable member arrangements enable the translatable member to flex around the curved slots 242 in the first and second jaws 220A, 220B. Thus, as the translatable member 240 is advanced distally by actuating the lever 128, the upper and lower flanged portions 244, 246 engage the first jaw 220A and the second jaw 220B to cam the jaws 220A, 220B together to clamp and cut tissue therebetween.



FIG. 6 illustrates another translatable member 240′ that is similar to translatable member 240 described above, except that a tissue-cutting wire 260 is provided between the upper and lower flanges for tissue cutting purposes. The wire 260 may be fabricated from, for example, stainless steel or the like and be mounted in tension between the upper flange 244 and the lower flange 246. The wire 260 may also be used in connection with a translatable member 240 that does not have the cutouts 252 in its flanges 244, 246. In an alternative embodiment, the wire 260 may be connected to the RF power source either directly or indirectly to cut electrically.


In various embodiments, the translatable member 240 may be provided with the cut outs 252 as described above and be fabricated from, for example, a relatively flexible or super elastic material or alloy such as Nitinol, NiTi or other alloys with similar properties. In other embodiments, the translatable member may be fabricated out of Nitinol, NiTi or similar material and have the shape of an I-beam without the cut outs 252 in the flanges. See FIG. 7.



FIGS. 8-11 illustrate another electrosurgical instrument 300 that employs another non-limiting end effector embodiment 400 of the present invention. The electrosurgical instrument 300 may be identical in construction and operation as electrical surgical instrument 100 except for the differences noted below. Turning to FIGS. 9 and 10, it can be seen that the end effector 400 includes a first jaw 420A and a second jaw 420B. The first jaw 420A may be pivotally coupled to the second jaw 420B to enable the first jaw 420A to pivot between an open position (FIG. 9) and a closed position (FIG. 10). First jaw 420A may comprise an upper first jaw body 431A that is formed from a series of vertically laminated layers 432A of material. In various embodiments, the laminated layers 432A may be fabricated from materials that comprise a thermal and/or electrical insulator, for example, zirconium, partially stabilized zirconium, aluminum oxide, silicon nitride, alumina-chromic, hydroxyapatite, other non-conductive glass materials, or other non-conductive ceramic materials. Other non-conductive glass-ceramic materials may also be employed. The layers 432A may be vertically laminated together by an electrometric material 434A such as, for example, polyisoprene, silicone, etc. See FIG. 11. The laminated layers 432A may serve to define a slot 442A for accommodating a translatable member 240 or 240′ in the manner described above. The first jaw body 431A has an upper first outward-facing surface 433A and an upper first energy delivery surface 435A. As used herein, the term “vertically laminated” means that the layers of material extend perpendicular to a plane along with the energy delivery surface lies. Second jaw 420B may comprise a lower second jaw body 431B that is formed from another series of vertically laminated layers 432B that may be fabricated and laminated from the various materials described above. The second jaw body 431B may have a lower second outward-facing surface 433B and a lower second energy delivery surface 435B. First energy delivery surface 435A and second energy delivery surface 435B may both extend in a “U” shape about the distal end of the end effector 200.


As seen in FIG. 11, electrosurgical energy may be delivered through current paths 477 between first energy delivery surface 435A and second energy delivery surface 435B. Translatable member 240 may comprise an insulating layer to prevent member 240 from functioning as a conductive path for current delivery. Opposing first and second energy delivery surfaces 435A and 435B may carry variable resistive positive temperature coefficient (PTC) bodies or matrices that are coupled to electrical source 145 and controller 150 in series and parallel circuit components. First energy delivery surface 435A and the corresponding PTC body can have a negative polarity (−) while second energy delivery surface 435B and the corresponding PTC body can have a positive polarity (+). PTC materials will “trip” and become highly resistive or non-conductive once a selected trip temperature is exceeded. First energy delivery surface 435A and second energy delivery surface 435B can carry any of the PTC matrix and electrode components disclosed in U.S. Pat. No. 6,929,644 entitled ELECTROSURGICAL JAW STRUCTURE FOR CONTROLLED ENERGY DELIVERY and U.S. Pat. No. 6,770,072 entitled ELECTROSURGICAL JAW STRUCTURE FOR CONTROLLED ENERGY DELIVERY, the respective disclosures of which are each fully incorporated herein by reference. The use of PTC materials in electrosurgical instruments is also described in U.S. Pat. No. 7,112,201 entitled ELECTROSURGICAL JAW STRUCTURE FOR CONTROLLED ENERGY DELIVERY, U.S. Pat. No. 6,929,622 entitled ELECTROSURGICAL JAW STRUCTURE FOR CONTROLLED ENERGY DELIVERY, and U.S. Patent Application Publication No. 2010/0036370A1 entitled ELECTROSURGICAL INSTRUMENT JAW STRUCTURE WITH CUTTING TIP, the respective disclosures of which are each fully incorporated herein by reference. In various embodiments, however, the first energy delivery surface 435A and the second energy delivery surface 435B are each fabricated from layers that are laminated together by, for example, adhesive or mechanical means.



FIG. 12 is a top diagrammatical view of the end effector 400 and an actuating system 491 that may be employed to flex the end effector 400 between the three positions illustrated therein. As can be seen in that Figure, the actuating system 491 may comprise at least one “first” cable 492 attached to each of said first and second jaws 420A, 420B. That is at least one first cable 492 is attached to the first jaw 420A and at least one other first cable 492 is attached to the second jaw 420B. Likewise, at least one “second” cable 496 is attached to each of the first jaw 420A and the second jaw 420B. That is, at least one second cable 496 is attached to the first jaw 420A and at least one other second cable 496 is attached to the second jaw 420B. Such actuation system 491 enables the clinician to “pull” portions of the first jaw 420A and portions of the second jaw 420B out of axial alignment with the elongate shaft 106. That is, for example, the first cables 492 may be used to pull portions of the first and second jaws 420A, 420B to the left of axis 125 and the second cables 496 may be used to pull portions of the first and second jaws 420A, 420B to the right of the axis 125. The first cables 492 may extend through the hollow elongated shaft 106 to be coupled to a first actuation member 494 that is operably supported by the handle 105. See FIG. 12. Similarly, the second cables 496 may extend through the hollow elongated shaft 106 to be coupled to a left actuation member 498 that is operably supported by the handle 105. For example, each actuation member 494, 498 may comprise a lever arm, button, etc. that is movably supported on the handle 105 and coupled to the corresponding cables 492, 496 such that movement of the actuation member 494 in one direction applies tension to the cables 492 to cause the end effector to flex to one side of axis 125. Movement of the actuation members 494, 498 in other directions permits the cables 492, 496 to assume positions wherein the end effector 400 can assume a relatively coaxial orientation with the elongated shaft member 106 to permit insertion of the end effector 400 through a lumen that will accept the hollow elongated shaft member 106. Similarly, movement of the actuation member 498 in one direction applies tension to the cables 496 to flex the end effector 400 to another side of axis 125. The actuation members 494, 498 may be selectively lockable in the various positions using known locking arrangements. In still other embodiments, one or more motors may be employed to apply tension to and relieve tension from the cables to effectuate a desired flexing or bending of the end effector 400. It will be understood that the end effector 400 may otherwise operate in the various manners disclosed herein and that the unique and novel design of the translatable member 240 or 240′ may flex or bend to travel through the respective slots 442A, 442B.



FIGS. 13-17 illustrate an electrosurgical instrument 500 according to another non-limiting embodiment of the present invention. This embodiment may employ a handle 105′ that is somewhat similar to handle 105 described above. However, the electrosurgical instrument 500 does not employ a translatable member that is designed to cut tissue and close the jaws 520A and 520B of the end effector 510. In this embodiment, the second jaw 520B is coupled to a spine member 530 that extends through the hollow elongate tube 106 and is attached to the handle 105′. The proximal end of the hollow elongate tube 106 interfaces with a shuttle member 146 that is movably supported in handle 105′ and interfaces with the lever 128 such that pivotal movement of the lever arm 128 along path 129 will cause the shuttle 146 and elongate tube 106 to move axially relative to the handle 105′ and the spine member 530 as represented by arrow 523. See FIGS. 14 and 15. Such closure arrangements are generally known in the art relating to other forms of surgical instruments, such as, for example, endocutters and the like. See, for example, U.S. Pat. No. 7,588,176 entitled SURGICAL CUTTING INSTRUMENT WITH IMPROVED CLOSURE SYSTEM and U.S. Pat. No. 7,665,647 entitled SURGICAL CUTTING AND STAPLING DEVICE WITH CLOSURE APPARATUS FOR LIMITING MAXIMUM TISSUE COMPRESSION FORCE, the disclosures of which are herein incorporated by reference in their respective entireties.


Referring now to FIG. 15, the first jaw 520A is pivotally coupled to the second jaw 520B for selective pivotal travel relative to the second jaw 520B (represented by arrow 521) upon the axial movement of the elongate tube 106 represented by arrow 523. First jaw 520A may comprise an upper first jaw body 531A that is formed from a series of vertically laminated layers 532A. See FIG. 16. In various embodiments, the laminated layers 532A may be fabricated from materials that comprise a thermal and/or electrical insulator, for example, zirconium, partially stabilized zirconium, aluminum oxide, silicon nitride, alumina-chromic, hydroxyapatite, other non-conductive glass materials, or other non-conductive ceramic materials. Other non-conductive glass-ceramic materials may be employed. The layers 532A may be laminated together by an elastomeric material such as, for example, polyisoprene, silicone, etc. The first jaw body 531A has an upper first outward-facing surface 533A and an upper first energy delivery surface 535A. Second jaw 520B may comprise a lower second jaw body 531B that is formed from another series of laminated layers 532B that may be fabricated and laminated from the various materials described above. The second jaw body 531B may have a lower second outward-facing surface 533B and a lower second energy delivery surface 535B. First energy delivery surface 535A and second energy delivery surface 535B may both extend in a “U” shape about the distal end of the end effector 510 and comprise vertical laminated layers of material. As discussed above, electrosurgical energy may be delivered through current paths between first energy delivery surface 535A and second energy delivery surface 535B. The first energy delivery surface 535A and the second energy delivery surface 535B may be configured to contact tissue and deliver electrosurgical energy to engaged tissue which is adapted to seal or weld the tissue. Opposing first and second energy delivery surfaces 535A and 535B may carry a variable resistive positive temperature coefficient (PTC) layer 540 that is coupled to electrical source 145 and controller 150 in series and parallel circuit components. First energy delivery surface 535A and the corresponding PTC layer 540 can have a negative polarity (−) while second energy delivery surface 535B and the corresponding PTC body 540 can have a positive polarity (+). PTC materials will “trip” and become substantially more resistive or non-conductive once a selected trip temperature is exceeded. First energy delivery surface 535A and second energy delivery surface 435B can carry any of the PTC matrix and electrode components in a laminated arrangement. Controller 150 can regulate the electrical energy delivered by electrical source 145 which in turn delivers electrosurgical energy to first energy delivery surface 535A and second energy delivery surface 535B. The energy delivery may be initiated by activation button 124 operably engaged with lever arm 128 and in electrical communication with controller 150 via cable 152. As mentioned above, the electrosurgical energy delivered by electrical source 145 may comprise radio frequency “RF” energy.


To facilitate flexible travel of the end effector 510 in the manners, for example, depicted in FIG. 17, an actuating arrangement 600 of the type described above may be employed. In particular, the actuating arrangement may comprise left cables 602 and right cables 606 that are attached to the first jaw 520A and the second jaw 520B to essentially enable the clinician to “pull” the first jaw 520A and second jaw 520B to the left and right of the axis 125. The right cables 606 may extend through the hollow spine member 530 to be coupled to a right actuation member 608 that is operably supported by the handle 105′. See FIGS. 13 and 17. Similarly, the left cables 602 may extend through the hollow spine member 530 to be coupled to a left actuation member 604 that is operably supported by the handle 105′. For example, each actuation member 604, 608 may comprise a lever arm, button, etc. that is movably supported on the handle 105′ and coupled to the corresponding cables 602, 606 such that movement of the actuation member 604, 608 in one direction applies tension to the cables 602, 606 and movement of the actuation member 604, 608 in another direction permits the cables 602, 606 to assume positions wherein the end effector 510 can assume a relatively coaxial orientation with the elongated member 106 to permit insertion of the end effector 510 through a lumen that will accept the hollow elongated member 106. The actuation members 604, 608 may be selectively lockable in the various positions using known locking arrangements. In still other embodiments, one or more motors may be employed to apply tension to and relieve tension from the cables to effectuate a desired flexing of the end effector 510.



FIG. 18 illustrates an end effector 700 according to another non-limiting embodiment of the present invention. End effector 700 may comprise a flexible end effector of the type described above or it could be essentially rigid. The end effector 700 has a first jaw 720A that is movably supported relative to a second jaw 720B. In various non-limiting embodiments, for example, the first jaw 720A may be pivotally coupled to or is otherwise pivotable relative to a second jaw 720B by means of the axial displacement of the elongate tube 106 in the various manners described above. As with various other embodiments described above, the first jaw 720A has a first jaw body 731A that has a width “W”, an upper first outward-facing surface 733A, an upper first energy delivery surface 735A and a distal end 737A. Second jaw 720B may comprise a lower second jaw body 731B that also has a width “W′” which may or may not be identical to width “W” of the first jaw body 731A and thus enable the end effector 700 to be conveniently inserted through a trocar or other lumen. The second jaw body 731B may have a second outward-facing surface 733B, a second energy delivery surface 735B and a second distal end 737B. First energy delivery surface 735A and second energy delivery surface 735B may both extend in a “U” shape about the distal end of the end effector 700. The energy delivery surfaces 735A, 735B may otherwise operate in the various manners described above. In this embodiment, to assist the surgeon with dissecting the target tissue to be cauterized, a distally extending blunt tip 760 may be provided on one or both of the first and second jaws 735A, 735B. The blunt tip 760 may be relatively smooth or in other embodiments, the blunt tip 760 may be coated with or otherwise provided with fibrous structures 761 to allow better non-powered dissection. As can be seen in FIG. 18, the blunt tip 760 may have a diameter or width “D” that is less than the widths “W”, “W′” to enable the tip 760 to be more easily inserted into areas in which the jaws 720A, 720B could not otherwise enter. In still other embodiments, an electrode (not shown) may be provided in the tip 760 such that it is configured to work as a monopolar dissector or alternatively a bipolar dissector.


In other non-limiting embodiments, the end effector 700′ may have a blunt tip portion 760′ that is pivotally coupled to an extension 764 that protrudes from one or both of the first and second jaws 720A, 720B. See FIG. 19. The blunt tip portion 760′ may be pivotally coupled to the extension 764 by a hinge 766 that will frictionally retain the blunt tip portion 760′ in a desired articulated position. For example, the surgeon may bring the blunt tip portion 760′ into contact with tissue or other structure to pivot the blunt tip portion 760′ to a desired position about a vertical axis VA-VA that is substantially transverse to a longitudinal axis LA-LA. The blunt tip portion 760′ may be retained in that position by friction between the components of the hinge 766. While FIG. 19 illustrates that the blunt tip portion is attached to the extension 764 for pivotal travel about a vertical axis, the blunt tip portion 760′ may be attached to the extension 764 for selective pivotal travel about a horizontal axis (not shown). In still other non-limiting embodiments, the blunt tip portion 760′ may be movably coupled to the extension by a “universal” hinge arrangement that facilitates pivotal positioning of the blunt tip portion 760′ about a horizontal axis and a vertical axis and thereafter retained in such desired position by friction. In still other non-limiting embodiments, the blunt tip portion 760 may be attached to extension 764 by a plurality of hinges and intermediate tip portions to further enable the blunt tip portion to be positioned in a desired orientation for dissection purposes. Alternatively, the blunt tip portion may be formed on the jaw members(s) and be constructed of a malleable material that allows the user to pre-sect the shape prior to insertion into the patient or after insertion with the use of another instrument.



FIGS. 20 and 21 illustrate an end effector 800 of another non-limiting embodiment of the present invention that may be identical to the end effector 700 except for the differences noted below. End effector 800 may comprise a flexible end effector of the type described above or it could be essentially rigid (not capable of flexing out of axial alignment with the elongate tube 106). The end effector 800 has a first jaw 820A that is pivotally coupled to or is otherwise pivotable relative to a second jaw 820B by means of the axial displacement of the elongate tube 106 in the various manners described above. As with various other non-limiting embodiments described above, the first jaw 820A has a first jaw body 831A that has a first outward-facing surface 833A and a first energy delivery surface 835A. Second jaw 820B may comprise a lower second jaw body 831B that has a second outward-facing surface 833B and a second energy delivery surface 835B. First energy delivery surface 835A and second energy delivery surface 835B may both extend in a “U” shape about the distal end of the end effector 800. The energy delivery surfaces 835A, 835B may otherwise operate in the various manners described above. In this embodiment, to assist the surgeon with dissecting or otherwise separating the target tissue to be cauterized, a distally extending first tip 860A may be provided on the first jaw 820A and a distally extending second tip 860B may be provided on the second jaw 820B. The first tip 860A may have a tapered outwardly facing surface 861A and a relatively planar inwardly facing surface 862A. Tissue gripping grooves 865A or bumps or other structures may be provided on the outer facing surface 861A and or inwardly facing surface 862A. Similarly, the second tip 860B may have a tapered outwardly facing surface 861B and a relatively planar inwardly facing surface 862B. Tissue gripping grooves 865B or bumps or other structures may be provided on the outer facing surface 861B and/or the inwardly facing surface 862B.


In various non-limiting embodiments, the first and second tips 860A, 860B are not powered. In other non-limiting embodiments, however, the tip 860A comprises a portion of the first energy delivery surface 835A or otherwise has an electrode portion therein. Likewise, the second tip 860B comprises a portion of the second energy delivery surface 835B or otherwise has an electrode portion therein. When powered, the energy may arc from tip to tip in a bipolar configuration or tip to tissue in a monopolar configuration. FIG. 21 illustrates one potential use of the end effector 800 to separate or dissect tissue “T”.



FIGS. 22-25 illustrate an electrosurgical instrument 900 according to another non-limiting embodiment of the present invention. This non-limiting embodiment may employ a handle 105′ that is somewhat similar to handle 105 described above. However, the electrosurgical instrument 900 does not employ a translatable member that is designed to cut tissue and close the jaws 920A and 920B of an end effector 910. In this embodiment, the second jaw 920B is coupled to a spine member 930 (FIG. 23) that extends through the hollow elongate tube 106 and is attached to the handle 105′ in the manner described above. Axial travel of the elongate tube 106 causes the first jaw 920A to pivot relative to the second jaw 920B. Other jaw closing mechanisms may also be employed.


First jaw 920A may comprise a series of pivotally interconnected first body segments 922A as shown in FIGS. 23-25. The first body segments 922A are coupled together by a ball and socket-type joint arrangement 923A such that they may pivot relative to each other about a vertical axis VA-VA as shown in FIG. 23. Each first body segment 922A may be fabricated from, for example, a thermal and/or electrical insulator. For example, zirconium, partially stabilized zirconium, aluminum oxide, silicon nitride, alumina-chromic, hydroxyapatite, other non-conductive glass materials, other non-conductive ceramic materials, and other non-conductive glass-ceramic materials may be employed. Each first body segment 922B further has a first energy delivery electrode 935A mounted therein.


Similarly, the second jaw 920B may comprise a series of pivotally interconnected second body segments 922B that are pivotally interconnected by a ball and socket-type joint arrangement 923B as shown in FIGS. 24 and 25. The second body segments 922B are coupled together such that they may pivot relative to each other about the vertical axes VA-VA as shown in FIG. 23. Each second body segment 922B corresponds to a first body segment 922A and may be fabricated from, for example, the same or different material comprising the corresponding first body segment 922A. Each second body segment 922B further has a second energy delivery electrode 935B mounted therein that corresponds to, and is substantially vertically aligned with, the first energy delivery electrode 935A in the corresponding first body segment 922A. The first energy delivery electrodes 935A and the second energy delivery electrodes 935B may be configured to contact tissue and deliver electrosurgical energy to engaged tissue which is adapted to seal or weld the tissue. Opposing first and second energy delivery electrodes 935A and 935B may be coupled to electrical source 145 and controller 150 in series and parallel circuit components. First energy delivery electrode 935A and the first body segment 922A can have a negative polarity (−) while second energy delivery surface 935B and the corresponding second body segment 922B can have a positive polarity (+) or vice versa. The first and second body segments 922A, 922B materials may “trip” and become resistive or non-conductive once a selected trip temperature is exceeded. Controller 150 can regulate the electrical energy delivered by electrical source 145 which in turn delivers electrosurgical energy to the first energy delivery electrodes 935A and the second energy delivery electrodes 9353B. The energy delivery may be initiated by activation button 124 operably engaged with lever arm 128 and in electrical communication with controller 150 via cable 152. As mentioned above, the electrosurgical energy delivered by electrical source 145 may comprise radio frequency “RF” energy and may be either monopolar or bipolar in nature.


In various non-limiting embodiments, once the first body segments 922A are oriented in a desired orientation relative to each other, friction between the ball and socket components 923A serve to retain the first body segments 922A in that position. Similarly, once the second body segments 922B are oriented in a desired orientation relative to each other, friction between the ball and socket components 923B retain the second body segments 922B in that position. Optionally, a first locking cable 929A may extend from a locking mechanism on the handle 105′ through each first body segment 922A to the distal-most body segment 922A. Once the body segments 922A have been moved to a desired orientation, the surgeon may apply tension to the first locking cable 929A by means of the locking mechanism to pull the first body segments 922A together to thereby lock them in place. Likewise, a second locking cable 929B may extend from the locking mechanism 940 or another locking mechanism on the handle 105′ through each body segment 922B to the distal-most body segment 922B. Once the body segments 922B have been moved to the desired orientation, the surgeon may apply tension to the second locking cable 929B to pull the second body segments 922B together to thereby lock them in place.



FIGS. 26 and 27 illustrate a portion of an end effector 1000 of another non-limiting embodiment of the present invention that includes a first jaw 1020A and a second jaw 1020B. The first jaw 1020A may have a first tapered distal end portion 1021A and the second jaw 1020B may have a second tapered distal end portion 1021B that converges with the first tapered distal end portion 1021A to form a substantially conical end effector tip 1022 that is particularly well-suited for dissection purposes. The embodiment may further include a reciprocating I-beam member 1040 that may be identical in construction and operation as the I-beam members described above, except for the following differences. More specifically, as can be seen in FIG. 27, the I-beam member 1040 has an upper flange 1042 and a lower flange 1044 that are interconnected by a central web portion 1046. The central web portion 1046 extends through aligned slots (not shown) in the first jaw member 1020A and the second jaw member 1020B in the manner described above. The upper flange 1042 may ride in a groove, slot or recessed area in the first jaw member 1020A and the lower flange 1044 may ride in a groove, slot or recessed area in the second jaw member 1020B such that, as the I beam member 1040 is distally advanced through the first and second jaw members 1020A, 1020B, the upper and lower flanges 1042, 1044 pivot the first and second jaws 1020A, 1020B together in the manner described above. As can be most particularly seen in FIG. 27, the lower flange 1044 protrudes further in the distal direction than does the upper flange 1042. The portion of the central web 1046 that extends from the distal-most edge of the lower flange 1044 to the distal-most edge of the upper flange 1042 has a cutting edge 1047 formed thereon. In various embodiments, the cutting edge 1047 may have an arcuate profile when viewed from the side. See, for example, FIG. 27. Such “recessed” I-beam arrangement, with an arcuate cutting surface, in combination with the tapered distal tip of the end effector, allows some compression of the first and second jaws 1020A, 1020B without transecting the tissue clamped between the first and second jaws 1020A, 1020B. Stated another way, as the I-beam is advanced distally within the end effector, the portion of the cutting surface that protrudes out of the slot in the second jaw 1020B is proximal to the distal most end of the portion of I-beam advancing through the second jaw 1020B. In various applications, the jaws can be actuated to add surface coagulation to cutting for tissue laying on the extended portion of the lower jaw, for example. In still other non-limiting embodiments, the distal edge of the web (i.e., edge 1047) may have a “C” shape or “U” shape. Stated another way, when viewed from the side, the edge 1047 may form a substantially horizontal “U” shape. Such unique I-beam configurations facilitate the compression of tissue between the jaws which serves to drive out water from the tissue. Current is then applied to the compressed tissue before it is ultimately cut with the advancing cutting edge. As a result, more robust seals are generally attained.



FIGS. 28-31 illustrate an electrosurgical instrument 1100 according to another non-limiting embodiment of the invention. Electrosurgical instrument 1100 comprises a proximal handle end 105″, a distal end effector 1200 and an introducer or elongate shaft member 1106 disposed in-between. In this non-limiting embodiment, however, the elongate shaft member 1106 includes a flexible spine assembly 1110 that is enclosed in a flexible hollow sheath 1112.



FIGS. 29-31 illustrate various spine assembly components. In particular, in at least one non-limiting embodiment, the spine assembly 1110 may be fabricated from a plurality of interconnected spine segments 1120. As can be seen in FIGS. 30 and 31, each spine segment 1120 has a hollow body 1122 that is somewhat cylindrical in shape. One end of the hollow body 1122 has an outwardly protruding ball member 1124 formed thereon. The other end of the body 1122 has a socket 1126 that is sized to rotatably receive and retain the ball member 1124 of an adjacent segment 1120 therein. In various embodiments, the proximal-most segment 1122 may be non-movably attached to actuator wheel 107 rotatably supported on the handle 105″. See FIG. 28. Thus, rotation of the actuator wheel 107 will cause the spine assembly 1110 to rotate about axis 125. The distal-most spine segment 1120 is attached to the end effector 1200. In one embodiment, the end effector 1200 may include a set of operable-closeable jaws 1220A and 1220B. The end effector 1200 may be adapted for capturing, welding and transecting tissue. First jaw 1220A and second jaw 1220B may close to thereby capture or engage tissue therebetween. First jaw 1220A and second jaw 1220B may also apply compression to the tissue. The second jaw 1220B may be attached to the distal-most spine segment 1120 and the first jaw 1220A may be pivotally or otherwise movably coupled to the second jaw 1220B. In one embodiment, for example, the end effector 1200 may be identical in construction and operation to end effector 200 described in detail above.


The electrosurgical instrument 1110 may also employ a translatable, reciprocating member or reciprocating “I-beam” member 240. The lever arm 128 of handle 105″ may be adapted to actuate a flexible translatable member 240 which also functions as a jaw-closing mechanism. For example, translatable member 240 may be urged distally as lever arm 128 is pulled proximally along path 129. The distal end of translatable member 240 comprises a flexible flanged “I”-beam that is configured to interface with the first and second jaw members 1220A, 1220B in the manner described above. The flexible translatable member 240 extends through the lumen 1130 provided through each spine segment 1120. See FIG. 31. The distal end of the flexible translatable member 240 interfaces with the first and second jaws 1220A, 1220B in the manner described above. Wires for powering the end effector 1200 may also extend through the lumen 1130 or extend through other passages (not shown) in the spine segments 1120. The unique and novel aspects of the spine assembly 1110 may also be employed with a host of other end effector arrangements. For example, the lumens 1130 in the spine segments 1120 may accommodate a variety of different actuator arrangements, wires, cables etc. that may be used to control and actuate the end effector.


The spine assembly 1110 may be effectively flexed in more than two directions (some of which are represented by arrows 1111 in FIG. 29) by a control assembly generally designated as 1300. In various embodiments, for example, control assembly 1300 may comprise at least one actuation member 1310 that extends through corresponding aligned hollow lugs 1130 formed on the perimeter of the hollow body 1122 of each spine segment 1120. In the depicted embodiment, the actuation members 1310 comprise four control cables. In alternative embodiments, however, three control cables could be employed to essentially achieve the same degrees of motion achieved with four cables. U.S. Pat. No. 8,262,563, entitled ENDOSCOPIC TRANSLUMENAL ARTICULATABLE STEERABLE OVERTUBE, the disclosure of which is herein incorporated by reference, discloses other steerable tubular arrangements that may be employed. In alternative embodiments, the control members 1310 may also comprise electrical conductors that communicate with the RF source to carry the RF energy to the end effector.


In the illustrated non-limiting embodiment, each spine segment 1122 has four diametrically opposed lugs 1130 formed thereon. Each of the control cables 1310 extend through the hollow sheath 1106 and into the handle 105″ to interface with articulation control mechanism 1400. In the depicted embodiment, the articulation control mechanism 1400 comprises a joy stick arrangement 1402 that is operably supported by the handle 105″. Thus, movement of the joy stick arrangement 1402 will apply tension to one or more of the cables 1310 to thereby cause the spine assembly 1110 to articulate. Other cable control arrangements could also be employed.



FIGS. 33-35 illustrate a monopolar electrosurgical instrument 1500 according to another non-limiting embodiment of the present invention. Electrosurgical instrument 1500 comprises a proximal handle 105, a distal end effector 1600, and an introducer or elongated shaft member 106 disposed in-between. The end effector 1600 in conjunction with a return pad (not shown) may be adapted for controlled surface ablation in Barrett's esophagus, liver or endometriosis procedures. As will be discussed in further detail below, the end effector 1600 is movable relative to the elongate shaft 106 which makes it particularly well-suited for laparoscopic or open procedural use.


Handle 105 may comprise a lever arm 128 which may be pulled along a path 129. The handle 105 can be any type of pistol-grip or other type of handle known in the art that is configured to carry actuator levers, triggers, etc. Elongate shaft 106 may have a cylindrical or rectangular cross-section and can comprise a thin-wall tubular sleeve that extends from handle 105. Elongate shaft 106 may be fabricated from, for example, metal such as stainless steel or plastics such as Ultem®, or Vectra®, etc. In still other embodiments, the elongate shaft 106 may comprise a polyolefin heat shrunk tube and have a bore extending therethrough for carrying actuator cables or members as well as for carrying electrical leads for delivery of electrical energy to electrosurgical components of end effector 1600. The elongate shaft member 106 along with the end effector 1600 may, in some embodiments, be rotatable a full 360° about an axis 125, relative to handle 105 through, for example, a rotary triple contact.


The end effector 1600 may comprise a pad support 1602 that is pinned or otherwise movably coupled to a distal end 107 of the elongate shaft 106. In various embodiments, the pad support 1602 may be fabricated from relatively flexible material such as, for example, poly carbonate or a relatively high durometer silicone elastomer. However, other materials may be employed. Attached to the flexible pad support 1602 is a conductor or electrode element 1604 and a flexible pad member 1606 that is fabricated from positive temperature coefficient (PTC) material. For example, the flexible pad member 1604 may be fabricated from that PTC material disclosed in U.S. Pat. No. 6,770,072, entitled ELECTROSURGICAL JAW STRUCTURE FOR CONTROLLED ENERGY DELIVERY, the disclosure of which is herein incorporated by reference in its entirety. The conductor or electrode element 1604 may be fabricated from, for example, metals such as stainless steel or copper and be coupled to an RF source 145 and controller 150 through electrical leads in cable 152. Such end effector 1600 includes an activation control button 131 that facilitates the application of controlled energy to tissue. The energy delivery may be initiated by activation button 131 in electrical communication with controller 150 via cable 152. As mentioned above, the electrosurgical energy delivered by electrical source 145 may comprise radio frequency “RF”. Lever 128 can provide control of the pad support 1602 relative to the elongate shaft 106 for better alignment and approximation of the pad 1602 to the tissue. The lever 128 may alternatively control articulation of the elongate shaft proximal the distal end of the elongate shaft 107.


This embodiment of the present invention provides the ability to supply current/power to targeted tissue at a predetermined critical temperature level. This is accomplished when the applied RF energy to the tissue reaches the point in time that the PTC pad 1606 is heated to its selected switching range. Thereafter, current flow from the conductive electrode 1604 through the flexible pad 1606 will be terminated due to the exponential increase in the resistance of the PTC to provide instant and automatic reduction of RF energy. Thus, the end effector 1600 can automatically modulate the application of energy to tissue between active RF heating and passive conductive heating to maintain a target temperature level. In various embodiments, the PTC pad 1606 is engineered to exhibit a dramatically increasing resistance above a specific temperature of the material. The energy delivery electrode 1604 is applied internally to the patient's body. A grounding pad applied externally to the patient's body completes the circuit. The PTC material 1606 will “trip” and become resistive or non-conductive once a selected trip temperature is exceeded. As can be seen in FIG. 35, the flexible nature of the end effector components enables the end effector to somewhat conform to irregular tissue “T”. These various embodiments may be employed to treat tissues, such as, for example, liver tissue, lung tissue cardiac tissue, prostate tissue breast tissue vascular tissue, etc. by the application of radio frequencies thereto. The device can be constructed for laparoscopic or open procedures. The flexible end effector can be designed to allow access through an access port such as a trocar. Further, the end effector can effectively apply controlled energy to the tissue. The term “controlled” refers to the ability to provide current/power to targeted tissue at a predetermined critical temperature level. This may be accomplished when the RF energy is applied to the tissue reaches the point in time that the PTC material is heated to is selected switching range. Thereafter, current flow from the conductive electrode through the flexible engagement surface may be terminated due to the exponential increase in the resistance of the PTC to provide instant and automatic reduction of RF energy. Thus, the flexible end effector can automatically modulate the application of energy to tissue between active RF heating and passive conduct heating to maintain a target temperature level.



FIGS. 36 and 37 depict another end effector 1600′ that is similar to end effector 1600 described above except for the differences noted below. As can be seen in FIG. 36, the elongate shaft 106 is attached to a yoke 109. The elongate shaft 106 may be fabricated from an insulator material such as Ultem®, Vectra, etc. or a conductive material such as stainless steel. In other embodiments, for example, the elongate shaft 106 may be fabricated from a polyolefin heat shrunk tube. Yoke 109 may be fabricated from an elastomer such as, for example, polyurethane or a shrink material such as a polyolefin, polyvinylchloride (PVC) or Neoprene. Yoke 109 is pivotally attached to a rigid pad portion 1620 that may be fabricated from, for example, polycarbonate or a high durometer silicone elastomer. The rigid pad portion 1620 is attached to a flexible pad portion 1622 by, for example, an elastomeric adhesive or overmolding process. Flexible pad portion 1622 may be fabricated from polyisoprene or silicone. The flexible pad portion 1622 may also be fabricated from closed or open cell Neoprene or silicone foam. In the embodiment depicted in FIG. 36, two (conductive) made from stainless steel, copper, etc.) electrodes 1630 are attached to the flexible pad portion 1622 by, for example, an elastomeric adhesive and are attached to the controller and source of RF energy by cables that extend through the elongate shaft 106 and handle. In one non-limiting embodiment, the two electrodes 1630 may serve as the source and return of the electrical circuit, as in a bipolar instrument. In another non-limiting embodiment, the two electrodes may be electrically connected and serve as a single source with an external patient return as in a monopolar instrument. In other embodiments, a single conductive electrode which may be substantially coextensive with the flexible pad portion may be employed. A flexible PTC member 1640 may be attached to the electrode(s) 1630 by, for example, adhesive or mechanically attached. This embodiment may be operated in the manner described above.


The devices disclosed herein may be designed to be disposed of after a single use, or they may be designed to be used multiple times. In either case, however, the device may be reconditioned for reuse after at least one use. Reconditioning may include a combination of the steps of disassembly of the device, followed by cleaning or replacement of particular pieces, and subsequent reassembly. In particular, the device may be disassembled, and any number of particular pieces or parts of the device may be selectively replaced or removed in any combination. Upon cleaning and/or replacement of particular parts, the device may be reassembled for subsequent use either at a reconditioning facility, or by a surgical team immediately prior to a surgical procedure. Those of ordinary skill in the art will appreciate that the reconditioning of a device may utilize a variety of different techniques for disassembly, cleaning/replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of this application.


Preferably, the various embodiments of the devices described herein will be processed before surgery. First, a new or used instrument is obtained and if necessary cleaned. The instrument can then be sterilized. In one sterilization technique, the instrument is placed in a closed and sealed container, such as a plastic or TYVEK® bag. The container and instrument are then placed in a field of radiation that can penetrate the container, such as gamma radiation, x-rays, or high-energy electrons. The radiation kills bacteria on the instrument and in the container. The sterilized instrument can then be stored in the sterile container. The sealed container keeps the instrument sterile until it is opened in the medical facility. Other sterilization techniques can be done by any number of ways known to those skilled in the art including beta or gamma radiation, ethylene oxide, and/or steam.


Any patent, publication, or other disclosure material, in whole or in part, that is said to be incorporated by reference herein is incorporated herein only to the extent that the incorporated materials does not conflict with existing definitions, statements, or other disclosure material set forth in this disclosure. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.

Claims
  • 1. A surgical instrument, comprising: an elongate shaft;an end effector extending from said elongate shaft, said end effector comprising: a first member; anda second member, wherein said first member is movable relative to said second member to transition said end effector between an open configuration and an approximated configuration to clamp tissue between said first member and said second member; anda camming assembly movable along a curved path, said camming assembly comprising: a first camming member, wherein said first camming member comprises: a first distal camming portion;a first proximal camming portion; anda first flexible portion extending between said first distal camming portion and said first proximal camming portion;a second camming member, wherein said second camming member comprises: a second distal camming portion;a second proximal camming portion; anda second flexible portion extending between said second distal camming portion and said second proximal camming portion; anda connector at least partially disposed between said first camming member and said second camming member, wherein said connector comprises a cutting member at a distal portion thereof, and wherein said camming assembly is movable relative to said end effector to exert a camming force against said first member and said second member to transition said end effector to said approximated configuration.
  • 2. The surgical instrument of claim 1, wherein at least one of said first flexible portion and said second flexible portion is fabricated from an elastic alloy.
  • 3. The surgical instrument of claim 1, wherein said elongate shaft comprises a flexible portion.
  • 4. The surgical instrument of claim 1, wherein at least one of said first member and said second member comprises an electrode.
  • 5. The surgical instrument of claim 1, wherein at least one of said first camming member and said second camming member defines a plane intersected by said cutting member.
  • 6. The surgical instrument of claim 1, wherein said first member comprises a first channel configured to receive at least a portion of said first camming member.
  • 7. The surgical instrument of claim 6, wherein said second member comprises a second channel configured to receive at least a portion of said second camming member.
  • 8. The surgical instrument of claim 1, wherein at least one of said first flexible portion and said second flexible portion comprises a plurality of cutout portions.
  • 9. The surgical instrument of claim 8, wherein each said cutout portion comprises a first region and a second region, wherein said first region is narrower than said second region, and wherein said second region is further away from said connector than said first region.
  • 10. The surgical instrument of claim 1, wherein said first flexible portion comprises a first plurality of cutout portions, wherein said second flexible portion comprises a second plurality of cutout portions, and wherein at least one of said first plurality of cutout portions is aligned with at least one of said second plurality of cutout portions.
  • 11. The surgical instrument of claim 1, wherein said camming assembly is formed in the shape of an I-beam.
  • 12. A surgical instrument, comprising: an elongate shaft;an end effector extending from said elongate shaft, said end effector comprising: a first jaw; anda second jaw, wherein said first jaw is movable relative to said second jaw to transition said end effector between an open configuration and an approximated configuration to clamp tissue between said first jaw and said second jaw; anda bendable firing member movable along a non-linear path, said bendable firing member comprising: a first bendable portion defining a first plane, said first bendable portion comprising a first camming surface at a distal portion thereof;a second bendable portion defining a second plane, said second bendable portion comprising a second camming surface at a distal portion thereof; anda connector defining a third plane intersecting said first plane and said second plane, wherein said connector comprises a cutting member at a distal portion thereof, and wherein said first camming surface and said second camming surface are configured to engage said first jaw and said second jaw respectively to transition said end effector to said approximated configuration.
  • 13. The surgical instrument of claim 12, wherein at least one of said first bendable portion and said second bendable portion is fabricated from an elastic alloy.
  • 14. The surgical instrument of claim 12, wherein said elongate shaft comprises a bendable portion.
  • 15. The surgical instrument of claim 12, wherein at least one of said first jaw and said second jaw comprises an electrode.
  • 16. The surgical instrument of claim 12, wherein said first jaw comprises a first channel configured to receive said first camming surface.
  • 17. The surgical instrument of claim 16, wherein said second jaw comprises a second channel configured to receive said second camming surface.
  • 18. The surgical instrument of claim 12, wherein at least one of said first bendable portion and said second bendable portion comprises a plurality of cutout portions.
  • 19. The surgical instrument of claim 18, wherein each said cutout portion comprises a first region and a second region, wherein said first region is narrower than said second region, and wherein said second region is further away from said connector than said first region.
  • 20. An end effector for use with a surgical instrument, said end effector comprising: a first jaw;a second jaw, wherein said first jaw is movable relative to said second jaw to transition said end effector between an open configuration and an approximated configuration to clamp tissue between said first jaw and said second jaw; anda camming assembly movable along a curved path, said camming assembly comprising: a first camming member, wherein said first camming member comprises: a first distal camming portion;a first proximal camming portion; anda first flexible portion extending between said first distal camming portion and said first proximal camming portion;a second camming member; anda connector at least partially disposed between said first camming member and said second camming member, wherein said connector comprises a cutting member at a distal portion thereof, and wherein said camming assembly is movable relative to said end effector to exert a camming force against said first jaw and said second jaw to transition said end effector to said approximated configuration.
  • 21. The surgical instrument of claim 20, wherein said first flexible portion comprises a plurality of recesses.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a continuation application claiming priority under 35 U.S.C. §120 to U.S. patent application Ser. No. 12/781,243, entitled SURGICAL INSTRUMENTS AND END EFFECTORS THEREFOR, filed May 17, 2010, U.S. Pat. No. 8,685,020, the entire disclosure of which is hereby incorporated by reference herein.

US Referenced Citations (655)
Number Name Date Kind
2366274 Luth et al. Jan 1945 A
2458152 Eakins Jan 1949 A
2510693 Green Jun 1950 A
2867039 Zach Jan 1959 A
3166971 Stoecker Jan 1965 A
3525912 Wallin Aug 1970 A
3580841 Cadotte et al. May 1971 A
3703651 Blowers Nov 1972 A
3777760 Essner Dec 1973 A
4005714 Hiltebrandt Feb 1977 A
4034762 Cosens et al. Jul 1977 A
4058126 Leveen Nov 1977 A
4203430 Takahashi May 1980 A
4220154 Semm Sep 1980 A
4237441 van Konynenburg et al. Dec 1980 A
4281785 Brooks Aug 1981 A
4304987 van Konynenburg Dec 1981 A
4463759 Garito et al. Aug 1984 A
4492231 Auth Jan 1985 A
4535773 Yoon Aug 1985 A
4545926 Fouts, Jr. et al. Oct 1985 A
4550870 Krumme et al. Nov 1985 A
4582236 Hirose Apr 1986 A
4617927 Manes Oct 1986 A
4735603 Goodson et al. Apr 1988 A
4761871 O'Connor et al. Aug 1988 A
4830462 Karny et al. May 1989 A
4849133 Yoshida et al. Jul 1989 A
4860745 Farin et al. Aug 1989 A
4878493 Pasternak et al. Nov 1989 A
4880015 Nierman Nov 1989 A
4910389 Sherman et al. Mar 1990 A
4920978 Colvin May 1990 A
4936842 D'Amelio et al. Jun 1990 A
5020514 Heckele Jun 1991 A
5061269 Muller Oct 1991 A
5099840 Goble et al. Mar 1992 A
5104025 Main et al. Apr 1992 A
5106538 Barma et al. Apr 1992 A
5108383 White Apr 1992 A
5156633 Smith Oct 1992 A
5160334 Billings et al. Nov 1992 A
5190541 Abele et al. Mar 1993 A
5196007 Ellman et al. Mar 1993 A
5205459 Brinkerhoff et al. Apr 1993 A
5217460 Knoepfler Jun 1993 A
5234428 Kaufman Aug 1993 A
5258006 Rydell et al. Nov 1993 A
5285945 Brinkerhoff et al. Feb 1994 A
5290286 Parins Mar 1994 A
5309927 Welch May 1994 A
5318564 Eggers Jun 1994 A
5318589 Lichtman Jun 1994 A
5330471 Eggers Jul 1994 A
5330502 Hassler et al. Jul 1994 A
5339723 Huitema Aug 1994 A
5342359 Rydell Aug 1994 A
5361583 Huitema Nov 1994 A
5383874 Jackson et al. Jan 1995 A
5387207 Dyer et al. Feb 1995 A
5389098 Tsuruta et al. Feb 1995 A
5395312 Desai Mar 1995 A
5395363 Billings et al. Mar 1995 A
5395364 Anderhub et al. Mar 1995 A
5396900 Slater et al. Mar 1995 A
5403312 Yates et al. Apr 1995 A
5417709 Slater May 1995 A
5428504 Bhatla Jun 1995 A
5429131 Scheinman et al. Jul 1995 A
5443463 Stern et al. Aug 1995 A
5445638 Rydell et al. Aug 1995 A
5451227 Michaelson Sep 1995 A
5458598 Feinberg et al. Oct 1995 A
5465895 Knodel et al. Nov 1995 A
5472443 Cordis et al. Dec 1995 A
5476479 Green et al. Dec 1995 A
5480409 Riza Jan 1996 A
5484436 Eggers et al. Jan 1996 A
5486189 Mudry et al. Jan 1996 A
5496317 Goble et al. Mar 1996 A
5504650 Katsui et al. Apr 1996 A
5509922 Aranyi et al. Apr 1996 A
5511556 DeSantis Apr 1996 A
5520704 Castro et al. May 1996 A
5522839 Pilling Jun 1996 A
5531744 Nardella et al. Jul 1996 A
5542916 Hirsch et al. Aug 1996 A
5558671 Yates Sep 1996 A
5563179 Stone et al. Oct 1996 A
5571121 Heifetz Nov 1996 A
5573534 Stone Nov 1996 A
5584830 Ladd et al. Dec 1996 A
5599350 Schulze et al. Feb 1997 A
5607450 Zvenyatsky et al. Mar 1997 A
5611813 Lichtman Mar 1997 A
5618307 Donlon et al. Apr 1997 A
5624452 Yates Apr 1997 A
5632432 Schulze et al. May 1997 A
5647871 Levine et al. Jul 1997 A
5658281 Heard Aug 1997 A
5662667 Knodel Sep 1997 A
5665085 Nardella Sep 1997 A
5665100 Yoon Sep 1997 A
5674219 Monson et al. Oct 1997 A
5674220 Fox et al. Oct 1997 A
5688270 Yates et al. Nov 1997 A
5693051 Schulze et al. Dec 1997 A
5709680 Yates et al. Jan 1998 A
5713896 Nardella Feb 1998 A
5716366 Yates Feb 1998 A
5735848 Yates et al. Apr 1998 A
5743906 Parins et al. Apr 1998 A
5752973 Kieturakis May 1998 A
5755717 Yates et al. May 1998 A
5762255 Chrisman et al. Jun 1998 A
5779701 McBrayer et al. Jul 1998 A
5782834 Lucey et al. Jul 1998 A
5792135 Madhani et al. Aug 1998 A
5792138 Shipp Aug 1998 A
5796188 Bays Aug 1998 A
5797941 Schulze et al. Aug 1998 A
5800432 Swanson Sep 1998 A
5800449 Wales Sep 1998 A
5807393 Williamson, IV et al. Sep 1998 A
5810811 Yates et al. Sep 1998 A
5817033 DeSantis et al. Oct 1998 A
5817084 Jensen Oct 1998 A
5817093 Williamson, IV et al. Oct 1998 A
5836909 Cosmescu Nov 1998 A
5836943 Miller, III Nov 1998 A
5853412 Mayenberger Dec 1998 A
5876401 Schulze et al. Mar 1999 A
5878193 Wang et al. Mar 1999 A
5880668 Hall Mar 1999 A
5891142 Eggers et al. Apr 1999 A
5906625 Bito et al. May 1999 A
5921956 Grinberg et al. Jul 1999 A
5984938 Yoon Nov 1999 A
6003517 Sheffield et al. Dec 1999 A
6013052 Durman et al. Jan 2000 A
6024741 Williamson, IV et al. Feb 2000 A
6024744 Kese et al. Feb 2000 A
6033399 Gines Mar 2000 A
6039734 Goble Mar 2000 A
6050996 Schmaltz et al. Apr 2000 A
6063098 Houser et al. May 2000 A
6068629 Haissaguerre et al. May 2000 A
6074389 Levine et al. Jun 2000 A
6091995 Ingle et al. Jul 2000 A
6099483 Palmer et al. Aug 2000 A
6099550 Yoon Aug 2000 A
H1904 Yates et al. Oct 2000 H
6132368 Cooper Oct 2000 A
6144402 Norsworthy et al. Nov 2000 A
6152923 Ryan Nov 2000 A
6162208 Hipps Dec 2000 A
6174309 Wrublewski et al. Jan 2001 B1
6190386 Rydell Feb 2001 B1
6206876 Levine et al. Mar 2001 B1
6228080 Gines May 2001 B1
6231565 Tovey et al. May 2001 B1
6259230 Chou Jul 2001 B1
6277117 Tetzlaff et al. Aug 2001 B1
6292700 Morrison et al. Sep 2001 B1
6325799 Goble Dec 2001 B1
6340878 Oglesbee Jan 2002 B1
6364888 Niemeyer et al. Apr 2002 B1
6391026 Hung et al. May 2002 B1
6398779 Buysse et al. Jun 2002 B1
H2037 Yates et al. Jul 2002 H
6419675 Gallo, Sr. Jul 2002 B1
6430446 Knowlton Aug 2002 B1
6443968 Holthaus et al. Sep 2002 B1
6458128 Schulze Oct 2002 B1
6464702 Schulze et al. Oct 2002 B2
6491690 Goble et al. Dec 2002 B1
6500112 Khouri Dec 2002 B1
6500176 Truckai Dec 2002 B1
6503248 Levine Jan 2003 B1
6511480 Tetzlaff et al. Jan 2003 B1
6514252 Nezhat et al. Feb 2003 B2
6517565 Whitman et al. Feb 2003 B1
6531846 Smith Mar 2003 B1
6533784 Truckai et al. Mar 2003 B2
6537272 Christopherson et al. Mar 2003 B2
6554829 Schulze et al. Apr 2003 B2
6558376 Bishop May 2003 B2
6572639 Ingle et al. Jun 2003 B1
6575969 Rittman, III et al. Jun 2003 B1
6584360 Francischelli et al. Jun 2003 B2
6585735 Frazier et al. Jul 2003 B1
6589200 Schwemberger et al. Jul 2003 B1
6602252 Mollenauer Aug 2003 B2
6620161 Schulze et al. Sep 2003 B2
6622731 Daniel et al. Sep 2003 B2
6623482 Pendekanti et al. Sep 2003 B2
6635057 Harano et al. Oct 2003 B2
6651669 Burnside Nov 2003 B1
6656177 Truckai Dec 2003 B2
6656198 Tsonton et al. Dec 2003 B2
6673248 Chowdhury Jan 2004 B2
6679882 Kornerup Jan 2004 B1
6695840 Schulze Feb 2004 B2
6722552 Fenton, Jr. Apr 2004 B2
6770072 Truckai et al. Aug 2004 B1
6773409 Truckai et al. Aug 2004 B2
6773435 Schulze et al. Aug 2004 B2
6775575 Bommannan et al. Aug 2004 B2
6783524 Anderson et al. Aug 2004 B2
6789939 Schrödinger et al. Sep 2004 B2
6796981 Wham et al. Sep 2004 B2
6800085 Selmon et al. Oct 2004 B2
6802843 Truckai et al. Oct 2004 B2
6811842 Ehrnsperger et al. Nov 2004 B1
6821273 Mollenauer Nov 2004 B2
6835199 McGuckin, Jr. et al. Dec 2004 B2
6840938 Morley et al. Jan 2005 B1
6860880 Treat et al. Mar 2005 B2
6905497 Truckai Jun 2005 B2
6908463 Treat et al. Jun 2005 B2
6913579 Truckai et al. Jul 2005 B2
6926716 Baker et al. Aug 2005 B2
6929622 Chian Aug 2005 B2
6929644 Truckai et al. Aug 2005 B2
6953461 McClurken et al. Oct 2005 B2
6994709 Iida Feb 2006 B2
7000818 Shelton, IV et al. Feb 2006 B2
7011657 Truckai et al. Mar 2006 B2
7041102 Truckai et al. May 2006 B2
7052496 Yamauchi May 2006 B2
7055731 Shelton, IV et al. Jun 2006 B2
7063699 Hess et al. Jun 2006 B2
7066936 Ryan Jun 2006 B2
7070597 Truckai et al. Jul 2006 B2
7083618 Couture et al. Aug 2006 B2
7083619 Truckai et al. Aug 2006 B2
7087054 Truckai et al. Aug 2006 B2
7094235 Francischelli et al. Aug 2006 B2
7101371 Dycus et al. Sep 2006 B2
7101372 Dycus et al. Sep 2006 B2
7101373 Dycus et al. Sep 2006 B2
7112201 Truckai et al. Sep 2006 B2
7118570 Tetzlaff et al. Oct 2006 B2
7125409 Truckai et al. Oct 2006 B2
7131970 Moses et al. Nov 2006 B2
7137980 Buysse et al. Nov 2006 B2
7143925 Shelton, IV et al. Dec 2006 B2
7147138 Shelton, IV Dec 2006 B2
7156846 Dycus et al. Jan 2007 B2
7160296 Pearson et al. Jan 2007 B2
7169146 Truckai et al. Jan 2007 B2
7169156 Hart Jan 2007 B2
7186253 Truckai et al. Mar 2007 B2
7189233 Truckai et al. Mar 2007 B2
7195631 Dumbauld Mar 2007 B2
7207471 Heinrich et al. Apr 2007 B2
7220951 Truckai et al. May 2007 B2
7225964 Mastri et al. Jun 2007 B2
7226448 Bertolero et al. Jun 2007 B2
7232440 Dumbauld et al. Jun 2007 B2
7235073 Levine et al. Jun 2007 B2
7241294 Reschke Jul 2007 B2
7251531 Mosher et al. Jul 2007 B2
7252667 Moses et al. Aug 2007 B2
7267677 Johnson et al. Sep 2007 B2
7267685 Butaric et al. Sep 2007 B2
7287682 Ezzat et al. Oct 2007 B1
7303557 Wham et al. Dec 2007 B2
7307313 Ohyanagi et al. Dec 2007 B2
7309849 Truckai et al. Dec 2007 B2
7311709 Truckai et al. Dec 2007 B2
7329257 Kanehira et al. Feb 2008 B2
7354440 Truckal et al. Apr 2008 B2
7357287 Shelton, IV et al. Apr 2008 B2
7364577 Wham et al. Apr 2008 B2
7367976 Lawes et al. May 2008 B2
7371227 Zeiner May 2008 B2
RE40388 Gines Jun 2008 E
7381209 Truckai et al. Jun 2008 B2
7384420 Dycus et al. Jun 2008 B2
7396356 Mollenauer Jul 2008 B2
7403224 Fuller et al. Jul 2008 B2
7404508 Smith et al. Jul 2008 B2
7407077 Ortiz et al. Aug 2008 B2
7422139 Shelton, IV et al. Sep 2008 B2
7435582 Zimmermann et al. Oct 2008 B2
7442193 Shields et al. Oct 2008 B2
7445621 Dumbauld et al. Nov 2008 B2
7464846 Shelton, IV et al. Dec 2008 B2
7473253 Dycus et al. Jan 2009 B2
7488319 Yates Feb 2009 B2
7491201 Shields et al. Feb 2009 B2
7494501 Ahlberg et al. Feb 2009 B2
7498080 Tung et al. Mar 2009 B2
7510107 Timm et al. Mar 2009 B2
7513025 Fischer Apr 2009 B2
7517349 Truckai et al. Apr 2009 B2
7524320 Tierney et al. Apr 2009 B2
7540872 Schechter et al. Jun 2009 B2
7550216 Ofer et al. Jun 2009 B2
7559452 Wales et al. Jul 2009 B2
7582086 Privitera et al. Sep 2009 B2
7586289 Andruk et al. Sep 2009 B2
7588176 Timm et al. Sep 2009 B2
7594925 Danek et al. Sep 2009 B2
7597693 Garrison Oct 2009 B2
7604150 Boudreaux Oct 2009 B2
7628791 Garrison et al. Dec 2009 B2
7628792 Guerra Dec 2009 B2
7632267 Dahla Dec 2009 B2
7632269 Truckai et al. Dec 2009 B2
7641653 Dalla Betta et al. Jan 2010 B2
7641671 Crainich Jan 2010 B2
7644848 Swayze et al. Jan 2010 B2
7645277 McClurken et al. Jan 2010 B2
7648499 Orszulak et al. Jan 2010 B2
7658311 Boudreaux Feb 2010 B2
7665647 Shelton, IV et al. Feb 2010 B2
7666206 Taniguchi et al. Feb 2010 B2
7691095 Bednarek et al. Apr 2010 B2
7691098 Wallace et al. Apr 2010 B2
7703459 Saadat et al. Apr 2010 B2
7703653 Shah et al. Apr 2010 B2
7708751 Hughes et al. May 2010 B2
7722527 Bouchier et al. May 2010 B2
7722607 Dumbauld et al. May 2010 B2
7753904 Shelton, IV et al. Jul 2010 B2
7753908 Swanson Jul 2010 B2
7762445 Heinrich et al. Jul 2010 B2
7766910 Hixson et al. Aug 2010 B2
7776037 Odom Aug 2010 B2
7780663 Yates et al. Aug 2010 B2
7784663 Shelton, IV Aug 2010 B2
7789883 Takashino et al. Sep 2010 B2
7803156 Eder et al. Sep 2010 B2
7806891 Nowlin et al. Oct 2010 B2
7815641 Dodde et al. Oct 2010 B2
7819298 Hall et al. Oct 2010 B2
7819299 Shelton, IV et al. Oct 2010 B2
7819872 Johnson et al. Oct 2010 B2
7824401 Manzo et al. Nov 2010 B2
7832408 Shelton, IV et al. Nov 2010 B2
7832612 Baxter, III et al. Nov 2010 B2
7846159 Morrison et al. Dec 2010 B2
7846160 Payne et al. Dec 2010 B2
7879035 Garrison et al. Feb 2011 B2
7879070 Ortiz et al. Feb 2011 B2
7896875 Heim et al. Mar 2011 B2
7901400 Wham et al. Mar 2011 B2
7909220 Viola Mar 2011 B2
7919184 Mohapatra et al. Apr 2011 B2
7931649 Couture et al. Apr 2011 B2
7935114 Takashino et al. May 2011 B2
7955331 Truckai et al. Jun 2011 B2
7963963 Francischelli et al. Jun 2011 B2
7967602 Lindquist Jun 2011 B2
7981113 Truckai et al. Jul 2011 B2
7997278 Utley et al. Aug 2011 B2
8020743 Shelton, IV Sep 2011 B2
8056720 Hawkes Nov 2011 B2
8058771 Giordano et al. Nov 2011 B2
8070036 Knodel et al. Dec 2011 B1
8105323 Buysse et al. Jan 2012 B2
8128624 Couture et al. Mar 2012 B2
8136712 Zingman Mar 2012 B2
8141762 Bedi et al. Mar 2012 B2
8157145 Shelton, IV et al. Apr 2012 B2
8197472 Lau et al. Jun 2012 B2
8197479 Olson et al. Jun 2012 B2
8221415 Francischelli Jul 2012 B2
8241235 Kahler et al. Aug 2012 B2
8246615 Behnke Aug 2012 B2
8246618 Bucciaglia et al. Aug 2012 B2
8251994 McKenna et al. Aug 2012 B2
8262563 Bakos et al. Sep 2012 B2
8267300 Boudreaux Sep 2012 B2
8277446 Heard Oct 2012 B2
8277447 Garrison et al. Oct 2012 B2
8282669 Gerber et al. Oct 2012 B2
8287528 Wham et al. Oct 2012 B2
8292886 Kerr et al. Oct 2012 B2
8298232 Unger Oct 2012 B2
8303583 Hosier et al. Nov 2012 B2
8323310 Kingsley Dec 2012 B2
8357158 McKenna et al. Jan 2013 B2
8377059 Deville et al. Feb 2013 B2
8397971 Yates et al. Mar 2013 B2
8414577 Boudreaux et al. Apr 2013 B2
8430876 Kappus et al. Apr 2013 B2
8453906 Huang et al. Jun 2013 B2
8460288 Tamai et al. Jun 2013 B2
8460292 Truckai et al. Jun 2013 B2
8486057 Behnke, II Jul 2013 B2
8496682 Guerra et al. Jul 2013 B2
8535311 Schall Sep 2013 B2
8540128 Shelton, IV et al. Sep 2013 B2
8562598 Falkenstein et al. Oct 2013 B2
8562604 Nishimura Oct 2013 B2
8568390 Mueller Oct 2013 B2
8568412 Brandt et al. Oct 2013 B2
8569997 Lee Oct 2013 B2
8574231 Boudreaux et al. Nov 2013 B2
8591506 Wham et al. Nov 2013 B2
8613383 Beckman et al. Dec 2013 B2
8623044 Timm et al. Jan 2014 B2
8628529 Aldridge et al. Jan 2014 B2
8632461 Glossop Jan 2014 B2
8647350 Mohan et al. Feb 2014 B2
8663222 Anderson et al. Mar 2014 B2
8684253 Giordano et al. Apr 2014 B2
8685020 Weizman et al. Apr 2014 B2
8696665 Hunt et al. Apr 2014 B2
8702609 Hadjicostis Apr 2014 B2
8702704 Shelton, IV et al. Apr 2014 B2
8709035 Johnson et al. Apr 2014 B2
8715270 Weitzner et al. May 2014 B2
8715277 Weizman May 2014 B2
8734443 Hixson et al. May 2014 B2
8747238 Shelton, IV et al. Jun 2014 B2
8747404 Boudreaux et al. Jun 2014 B2
8752264 Ackley et al. Jun 2014 B2
8752749 Moore et al. Jun 2014 B2
8753338 Widenhouse et al. Jun 2014 B2
8764747 Cummings et al. Jul 2014 B2
8790342 Stulen et al. Jul 2014 B2
8795276 Dietz et al. Aug 2014 B2
8834466 Cummings et al. Sep 2014 B2
8834518 Faller et al. Sep 2014 B2
8845630 Mehta et al. Sep 2014 B2
8888776 Dietz et al. Nov 2014 B2
8906016 Boudreaux et al. Dec 2014 B2
8926607 Norvell et al. Jan 2015 B2
8926608 Bacher et al. Jan 2015 B2
8931682 Timm et al. Jan 2015 B2
8939974 Boudreaux et al. Jan 2015 B2
8951248 Messerly et al. Feb 2015 B2
8956349 Aldridge et al. Feb 2015 B2
8979843 Timm et al. Mar 2015 B2
8979844 White et al. Mar 2015 B2
8979890 Boudreaux Mar 2015 B2
8986302 Aldridge et al. Mar 2015 B2
8992422 Spivey et al. Mar 2015 B2
9005199 Beckman et al. Apr 2015 B2
9011437 Woodruff et al. Apr 2015 B2
9028494 Shelton, IV et al. May 2015 B2
9028519 Yates et al. May 2015 B2
9044243 Johnson et al. Jun 2015 B2
9044256 Cadeddu et al. Jun 2015 B2
9060770 Shelton, IV et al. Jun 2015 B2
9072535 Shelton, IV et al. Jul 2015 B2
9072536 Shelton, IV et al. Jul 2015 B2
9101385 Shelton, IV et al. Aug 2015 B2
9119657 Shelton, IV et al. Sep 2015 B2
9125662 Shelton, IV Sep 2015 B2
9149324 Huang et al. Oct 2015 B2
9179912 Yates et al. Nov 2015 B2
9192431 Woodruff et al. Nov 2015 B2
9204879 Shelton, IV Dec 2015 B2
9226751 Shelton, IV et al. Jan 2016 B2
9237891 Shelton, IV Jan 2016 B2
9259265 Harris et al. Feb 2016 B2
9265926 Strobl et al. Feb 2016 B2
9283027 Monson et al. Mar 2016 B2
9295514 Shelton, IV et al. Mar 2016 B2
9314292 Trees et al. Apr 2016 B2
20020022836 Goble et al. Feb 2002 A1
20020165541 Whitman Nov 2002 A1
20030014053 Nguyen et al. Jan 2003 A1
20030105474 Bonutti Jun 2003 A1
20030114851 Truckai et al. Jun 2003 A1
20030130693 Levin et al. Jul 2003 A1
20030139741 Goble et al. Jul 2003 A1
20030158548 Phan et al. Aug 2003 A1
20030216722 Swanson Nov 2003 A1
20030229344 Dycus et al. Dec 2003 A1
20040019350 O'Brien et al. Jan 2004 A1
20040092992 Adams et al. May 2004 A1
20040138621 Jahns et al. Jul 2004 A1
20040167508 Wham et al. Aug 2004 A1
20040193150 Sharkey et al. Sep 2004 A1
20040232196 Shelton, IV et al. Nov 2004 A1
20040249374 Tetzlaff et al. Dec 2004 A1
20040260273 Wan Dec 2004 A1
20050015125 Mioduski et al. Jan 2005 A1
20050033278 McClurken et al. Feb 2005 A1
20050085809 Mucko et al. Apr 2005 A1
20050090817 Phan Apr 2005 A1
20050131390 Heinrich et al. Jun 2005 A1
20050165429 Douglas et al. Jul 2005 A1
20050171522 Christopherson Aug 2005 A1
20050203507 Truckai et al. Sep 2005 A1
20050261581 Hughes et al. Nov 2005 A1
20050267464 Truckai et al. Dec 2005 A1
20060052778 Chapman et al. Mar 2006 A1
20060064086 Odom Mar 2006 A1
20060069388 Truckai et al. Mar 2006 A1
20060159731 Shoshan Jul 2006 A1
20060270916 Skwarek et al. Nov 2006 A1
20060293656 Shadduck et al. Dec 2006 A1
20070027469 Smith et al. Feb 2007 A1
20070073185 Nakao Mar 2007 A1
20070073341 Smith et al. Mar 2007 A1
20070106158 Madan et al. May 2007 A1
20070146113 Truckai et al. Jun 2007 A1
20070173803 Wham et al. Jul 2007 A1
20070173813 Odom Jul 2007 A1
20070185474 Nahen Aug 2007 A1
20070191713 Eichmann et al. Aug 2007 A1
20070191830 Cromton, Jr. et al. Aug 2007 A1
20070203483 Kim et al. Aug 2007 A1
20070208312 Norton et al. Sep 2007 A1
20070232920 Kowalski et al. Oct 2007 A1
20070232926 Stulen et al. Oct 2007 A1
20070232927 Madan et al. Oct 2007 A1
20070232928 Wiener et al. Oct 2007 A1
20070236213 Paden et al. Oct 2007 A1
20070239025 Wiener et al. Oct 2007 A1
20070260242 Dycus et al. Nov 2007 A1
20070265613 Edelstein et al. Nov 2007 A1
20080015575 Odom et al. Jan 2008 A1
20080071269 Hilario et al. Mar 2008 A1
20080114355 Whayne et al. May 2008 A1
20080147058 Horrell et al. Jun 2008 A1
20080147062 Truckai et al. Jun 2008 A1
20080167522 Giordano et al. Jul 2008 A1
20080188755 Hart Aug 2008 A1
20080188851 Truckai et al. Aug 2008 A1
20080188912 Stone et al. Aug 2008 A1
20080221565 Eder et al. Sep 2008 A1
20080262491 Swoyer et al. Oct 2008 A1
20080269862 Elmouelhi et al. Oct 2008 A1
20080281315 Gines Nov 2008 A1
20080294158 Pappone et al. Nov 2008 A1
20090012516 Curtis et al. Jan 2009 A1
20090048589 Takashino et al. Feb 2009 A1
20090076506 Baker Mar 2009 A1
20090076534 Shelton, IV et al. Mar 2009 A1
20090099582 Isaacs et al. Apr 2009 A1
20090125026 Rioux et al. May 2009 A1
20090125027 Fischer May 2009 A1
20090138003 Deville et al. May 2009 A1
20090138006 Bales et al. May 2009 A1
20090182332 Long et al. Jul 2009 A1
20090206140 Scheib et al. Aug 2009 A1
20090209979 Yates et al. Aug 2009 A1
20090248002 Takashino et al. Oct 2009 A1
20090248021 McKenna Oct 2009 A1
20090320268 Cunningham et al. Dec 2009 A1
20090326530 Orban, III et al. Dec 2009 A1
20100032470 Hess et al. Feb 2010 A1
20100036370 Mirel et al. Feb 2010 A1
20100036380 Taylor et al. Feb 2010 A1
20100076433 Taylor et al. Mar 2010 A1
20100081863 Hess et al. Apr 2010 A1
20100081864 Hess et al. Apr 2010 A1
20100081880 Widenhouse et al. Apr 2010 A1
20100081881 Murray et al. Apr 2010 A1
20100081882 Hess et al. Apr 2010 A1
20100081883 Murray et al. Apr 2010 A1
20100081995 Widenhouse et al. Apr 2010 A1
20100094323 Isaacs et al. Apr 2010 A1
20100168620 Klimovitch et al. Jul 2010 A1
20100222752 Collins, Jr. et al. Sep 2010 A1
20100237132 Measamer et al. Sep 2010 A1
20100264194 Huang et al. Oct 2010 A1
20100274278 Fleenor et al. Oct 2010 A1
20110015627 DiNardo et al. Jan 2011 A1
20110082486 Messerly et al. Apr 2011 A1
20110087214 Giordano et al. Apr 2011 A1
20110087215 Aldridge et al. Apr 2011 A1
20110087216 Aldridge et al. Apr 2011 A1
20110087217 Yates et al. Apr 2011 A1
20110087220 Felder et al. Apr 2011 A1
20110118754 Dachs, II et al. May 2011 A1
20110155781 Swensgard et al. Jun 2011 A1
20110224668 Johnson et al. Sep 2011 A1
20110276049 Gerhardt Nov 2011 A1
20110276057 Conlon et al. Nov 2011 A1
20110284014 Cadeddu et al. Nov 2011 A1
20110290856 Shelton, IV et al. Dec 2011 A1
20110295269 Swensgard et al. Dec 2011 A1
20110295295 Shelton, IV et al. Dec 2011 A1
20110301605 Horner Dec 2011 A1
20110306967 Payne et al. Dec 2011 A1
20120016413 Timm et al. Jan 2012 A1
20120022519 Huang et al. Jan 2012 A1
20120022525 Dietz Jan 2012 A1
20120022526 Aldridge et al. Jan 2012 A1
20120078243 Worrell et al. Mar 2012 A1
20120078244 Worrell et al. Mar 2012 A1
20120078247 Worrell et al. Mar 2012 A1
20120078248 Worrell et al. Mar 2012 A1
20120083783 Davison et al. Apr 2012 A1
20120109186 Parrott et al. May 2012 A1
20120116265 Houser et al. May 2012 A1
20120116379 Yates et al. May 2012 A1
20120116380 Madan et al. May 2012 A1
20120116391 Houser et al. May 2012 A1
20120130256 Buysse et al. May 2012 A1
20120136353 Romero May 2012 A1
20120150170 Buysse et al. Jun 2012 A1
20120150192 Dachs, II et al. Jun 2012 A1
20120172859 Condie et al. Jul 2012 A1
20120265196 Turner et al. Oct 2012 A1
20130023925 Mueller Jan 2013 A1
20130030433 Heard Jan 2013 A1
20130079762 Twomey et al. Mar 2013 A1
20130085496 Unger et al. Apr 2013 A1
20130103023 Monson et al. Apr 2013 A1
20130103024 Monson et al. Apr 2013 A1
20130123776 Monson et al. May 2013 A1
20130131660 Monson et al. May 2013 A1
20130253256 Griffith et al. Sep 2013 A1
20130253502 Aronow et al. Sep 2013 A1
20130338661 Behnke, II Dec 2013 A1
20140001231 Shelton, IV et al. Jan 2014 A1
20140001234 Shelton, IV et al. Jan 2014 A1
20140001235 Shelton, IV Jan 2014 A1
20140001236 Shelton, IV et al. Jan 2014 A1
20140005640 Shelton, IV et al. Jan 2014 A1
20140005653 Shelton, IV et al. Jan 2014 A1
20140005678 Shelton, IV et al. Jan 2014 A1
20140005680 Shelton, IV et al. Jan 2014 A1
20140005693 Shelton, IV et al. Jan 2014 A1
20140005694 Shelton, IV et al. Jan 2014 A1
20140005695 Shelton, IV Jan 2014 A1
20140005718 Shelton, IV et al. Jan 2014 A1
20140014544 Bugnard et al. Jan 2014 A1
20140094801 Boudreaux et al. Apr 2014 A1
20140194914 Hunt et al. Jul 2014 A1
20140194915 Johnson et al. Jul 2014 A1
20140257284 Artale Sep 2014 A1
20140330271 Dietz et al. Nov 2014 A1
20140343550 Faller et al. Nov 2014 A1
20150018826 Boudreaux Jan 2015 A1
20150080876 Worrell et al. Mar 2015 A1
20150080879 Trees et al. Mar 2015 A1
20150080891 Shelton, IV et al. Mar 2015 A1
20150133915 Strobl et al. May 2015 A1
20150190189 Yates et al. Jul 2015 A1
20150196352 Beckman et al. Jul 2015 A1
20150201953 Strobl et al. Jul 2015 A1
20150230853 Johnson et al. Aug 2015 A1
20150265347 Yates et al. Sep 2015 A1
20150272602 Boudreaux et al. Oct 2015 A1
20150272657 Yates et al. Oct 2015 A1
20150272659 Boudreaux et al. Oct 2015 A1
20150272660 Boudreaux et al. Oct 2015 A1
20150289925 Voegele et al. Oct 2015 A1
20150297286 Boudreaux et al. Oct 2015 A1
20160051315 Boudreaux Feb 2016 A1
20160051316 Boudreaux Feb 2016 A1
20160051317 Boudreaux Feb 2016 A1
20160058492 Yates et al. Mar 2016 A1
20160074108 Woodruff et al. Mar 2016 A1
Foreign Referenced Citations (83)
Number Date Country
4300307 Jul 1994 DE
0340803 Aug 1993 EP
0630612 Dec 1994 EP
0705571 Apr 1996 EP
0557806 May 1998 EP
0640317 Sep 1999 EP
0722696 Dec 2002 EP
1293172 Apr 2006 EP
1749479 Feb 2007 EP
1767157 Mar 2007 EP
1878399 Jan 2008 EP
1915953 Apr 2008 EP
1532933 May 2008 EP
1707143 Jun 2008 EP
1943957 Jul 2008 EP
1849424 Apr 2009 EP
2042117 Apr 2009 EP
2060238 May 2009 EP
1810625 Aug 2009 EP
2090238 Aug 2009 EP
2090256 Aug 2009 EP
2092905 Aug 2009 EP
2105104 Sep 2009 EP
1747761 Oct 2009 EP
1769766 Feb 2010 EP
2151204 Feb 2010 EP
2153791 Feb 2010 EP
2243439 Oct 2010 EP
1728475 Aug 2011 EP
2353518 Aug 2011 EP
2578172 Apr 2013 EP
2508143 Feb 2014 EP
2472216 Feb 2011 GB
H08-229050 Sep 1996 JP
2008-018226 Jan 2008 JP
WO 8103272 Nov 1981 WO
WO 9307817 Apr 1993 WO
WO 9322973 Nov 1993 WO
WO 9510978 Apr 1995 WO
WO 9635382 Nov 1996 WO
WO 9710764 Mar 1997 WO
WO 9800069 Jan 1998 WO
WO 9840020 Sep 1998 WO
WO 9857588 Dec 1998 WO
WO 9923960 May 1999 WO
WO 9940861 Aug 1999 WO
WO 0024330 May 2000 WO
WO 0024331 May 2000 WO
WO 0025691 May 2000 WO
WO 0128444 Apr 2001 WO
WO 02080797 Oct 2002 WO
WO 03001986 Jan 2003 WO
WO 03013374 Feb 2003 WO
WO 03020339 Mar 2003 WO
WO 03028541 Apr 2003 WO
WO 03030708 Apr 2003 WO
WO 03068046 Aug 2003 WO
WO 2004011037 Feb 2004 WO
WO 2004078051 Sep 2004 WO
WO 2005052959 Jun 2005 WO
WO 2006021269 Mar 2006 WO
WO 2006036706 Apr 2006 WO
WO 2006055166 May 2006 WO
WO 2008020964 Feb 2008 WO
WO 2008045348 Apr 2008 WO
WO 2008099529 Aug 2008 WO
WO 2008101356 Aug 2008 WO
WO 2009022614 Feb 2009 WO
WO 2009036818 Mar 2009 WO
WO 2009039179 Mar 2009 WO
WO 2009059741 May 2009 WO
WO 2009082477 Jul 2009 WO
WO 2009149234 Dec 2009 WO
WO 2010017266 Feb 2010 WO
WO 2010104755 Sep 2010 WO
WO 2011084768 Jul 2011 WO
WO 2011089717 Jul 2011 WO
WO 2011144911 Nov 2011 WO
WO 2012044606 Apr 2012 WO
WO 2013034629 Mar 2013 WO
WO 2013062978 May 2013 WO
WO 2013154157 Oct 2013 WO
WO 2015197395 Dec 2015 WO
Non-Patent Literature Citations (35)
Entry
Partial International Search Report for PCT/US2011/036617, Sep. 6, 2011 (2 pages).
International Search Report for PCT/US2011/036617, Nov. 29, 2011 (9 pages).
International Preliminary Report on Patentability for PCT/US2011/036617, Nov. 20, 2012 (13 pages).
European Examination Report for Application No. 11722246.3, dated Sep. 24, 2013 (5 pages).
Written Opinion for PCT/US2011/036617, Nov. 29, 2011 (13 pages).
Weir, C.E., “Rate of shrinkage of tendon collagen—heat, entropy and free energy of activation of the shrinkage of untreated tendon. Effect of acid salt, pickle, and tannage on the activation of tendon collagen.” Journal of the American Leather Chemists Association, 44, pp. 108-140 (1949).
Hörmann et al., “Reversible and irreversible denaturation of collagen fibers.” Biochemistry, 10, pp. 932-937 (1971).
Henriques. F.C., “Studies in thermal injury V. The predictability and the significance of thermally induced rate processes leading to irreversible epidermal injury.” Archives of Pathology, 434, pp. 489-502 (1947).
Arnoczky et al., “Thermal Modification of Conective Tissues: Basic Science Considerations and Clinical Implications,” J. Am Acad Orthop Surg, vol. 8, No. 5, pp. 305-313 (Sep./Oct. 2000).
Chen et al., “Heat-induced changes in the mechanics of a collagenous tissue: pseudoelastic behavior at 37° C,” Journal of Biomechanics, 31, pp. 211-216 (1998).
Chen et al., “Heat-Induced Changes in the Mechanics of a Collagenous Tissue: Isothermal Free Shrinkage,” Transactions of the ASME, vol. 119, pp. 372-378 (Nov. 1997).
Chen et al., “Heat-Induced Changes in the Mechanics of a Collagenous Tissue: Isothermal, Isotonic Shrinkage,” Transactions of the ASME, vol. 120, pp. 382-388 (Jun. 1998).
Chen et al., “Phenomenological Evolution Equations for Heat-Induced Shrinkage of a Collagenous Tissue,” IEEE Transactions on Biomedical Engineering, vol. 45, No. 10, pp. 1234-1240 (Oct. 1998).
Harris et al., “Kinetics of Thermal Damage to a Collagenous Membrane Under Biaxial Isotonic Loading,” IEEE Transactions on Biomedical Engineering, vol. 51, No. 2, pp. 371-379 (Feb. 2004).
Harris et al., “Altered Mechanical Behavior of Epicardium Due to Isothermal Heating Under Biaxial Isotonic Loads,” Journal of Biomechanical Engineering, vol. 125, pp. 381-388 (Jun. 2003).
Hayashi et al., “The Effect of Thermal Heating on the Length and Histologic Properties of the Glenohumeral Joint Capsule,” American Journal of Sports Medicine, vol. 25, Issue 1, 11 pages (Jan. 1997), URL: http://www.mdconsult.com/das/article/body/156183648-2/jorg=journal&source=Ml&sp=1 . . . , accessed Aug. 25, 2009.
Lee et al., “A multi-sample denaturation temperature tester for collagenous biomaterials,” Med. Eng. Phy., vol. 17, No. 2, pp. 115-121 (Mar. 1995).
Moran et al., “Thermally Induced Shrinkage of Joint Capsule,” Clinical Orthopaedics and Related Research, No. 281, pp. 248-255 (Dec. 2000).
Wall et al., “Thermal modification of collagen,” J Shoulder Elbow Surg, No. 8, pp. 339-344 (Jul./Aug. 1999).
Wells et al., “Altered Mechanical Behavior of Epicardium Under Isothermal Biaxial Loading,” Transactions of the ASME, Journal of Biomedical Engineering, vol. 126, pp. 492-497 (Aug. 2004).
Gibson, “Magnetic Refrigerator Successfully Tested,” U.S. Department of Energy Research News, accessed online on Aug. 6, 2010 at http://www.eurekalert.org/features/doe/2001-11/dl-mrs062802.php (Nov. 1, 2001).
Humphrey, J.D., “Continuum Thermomechanics and the Clinical Treatment of Disease and Injury,” Appl. Mech. Rev., vol. 56, No. 2 pp. 231-260 (Mar. 2003).
Kurt Gieck & Reiner Gieck, Engineering Formulas § Z.7 (7th ed. 1997).
National Semiconductors Temperature Sensor Handbook—http://www.national.com/appinfo/tempsensors/files/temphb.pdf; accessed online: Apr. 1, 2011.
Wright, et al., “Time-Temperature Equivalence of Heat-Induced Changes in Cells and Proteins,” Feb. 1998. ASME Journal of Biomechanical Engineering, vol. 120, pp. 22-26.
Covidien Brochure, [Value Analysis Brief], LigaSure Advance™ Pistol Grip, dated Rev. Apr. 2010 (7 pages).
Covidien Brochure, LigaSure Impact™ Instrument LF4318, dated Feb. 2013 (3 pages).
Covidien Brochure, LigaSure Atlas™ Hand Switching Instruments, dated Dec. 2008 (2 pages).
Covidien Brochure, The LigaSure™ 5 mm Blunt Tip Sealer/Divider Family, dated Apr. 2013 (2 pages).
Covidien Brochure, The LigaSure Precise™ Instrument, dated Mar. 2011 (2 pages).
Erbe Electrosurgery VIO®200 S, (2012), p. 7, 12 pages, accessed Mar. 31, 2014 at http://www.erbe-med.com/erbe/media/Marketingmaterialien/85140-170—ERBE—EN—VIO—200—S—D027541.
Jang, J. et al. “Neuro-fuzzy and Soft Computing.” Prentice Hall, 1997, pp. 13-89, 199-293, 335-393,453-496, 535-549.
Douglas, S.C. “Introduction to Adaptive Filter”. Digital Signal Processing Handbook. Ed. Vijay K. Madisetti and Douglas B. Williams. Boca Raton: CRC Press LLC, 1999.
Sullivan, “Cost-Constrained Selection of Strand Diameter and Number in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 16, No. 2, Mar. 2001, pp. 281-288.
Sullivan, “Optimal Choice for Number of Strands in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 14, No. 2, Mar. 1999, pp. 283-291.
Related Publications (1)
Number Date Country
20140148806 A1 May 2014 US
Continuations (1)
Number Date Country
Parent 12781243 May 2010 US
Child 14171035 US